UGGT1

UniProt ID: Q9NYU2
Organism: Homo sapiens
Review Status: IN PROGRESS
📝 Provide Detailed Feedback

Gene Description

UDP-glucose:glycoprotein glucosyltransferase 1 (UGGT1) is a large (~173 kDa) soluble ER-resident enzyme that serves as the central quality control sensor and folding checkpoint in the calnexin/calreticulin cycle. UGGT1 recognizes glycoproteins with minor folding defects (preferentially molten-globule-like intermediates, not fully folded or completely unfolded proteins) and reglucosylates their N-glycans, thereby tagging them for re-engagement with the calnexin/calreticulin chaperone system. Its core molecular function is UDP-glucose:glycoprotein glucosyltransferase activity (EC 2.4.1.-), transferring glucose from UDP-glucose to deglucosylated high-mannose N-glycans on misfolded substrates. Structurally, UGGT1 has a seven-domain architecture: four N-terminal thioredoxin-like domains (TRXL1-TRXL4) arranged in an arc that mediate substrate recognition, two beta-sandwich domains (betaS1, betaS2), and the C-terminal GT24 catalytic domain (~20% of the protein) (DOI:10.1073/pnas.1703682114). Substantial interdomain conformational flexibility enables UGGT1 to accommodate diverse client shapes and to glucosylate glycans at least ~40 angstroms from localized disordered regions. UGGT1 writes a site-selective "glyco-code" that determines which ER chaperones engage substrates and when during maturation (DOI:10.1016/j.molcel.2023.11.006). UGGT1-mediated reglucosylation competes with EDEM-family mannose trimming in a "tug-of-war" that determines whether substrates are retained for refolding or committed to ERAD (DOI:10.1101/2023.10.18.562958). UGGT1 activity is modulated by the partner selenoprotein SELENOF/SEP15 (DOI:10.1073/pnas.2315009121). UGGT1 is the dominant mammalian reglucosyltransferase (UGGT2 is ~7-30% of UGGT1 abundance in tested cell lines). Described as a "gatekeeper for quality control" that prevents transport of improperly folded glycoproteins out of the ER (PMID:10694380).

Existing Annotations Review

GO Term Evidence Action Reason
GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for the core enzymatic function of UGGT1. This is the defining molecular function of UGGT1: it transfers glucose from UDP-glucose to Man9GlcNAc2 N-glycans on misfolded glycoproteins. This activity has been experimentally demonstrated in PMID:10694380 (27-fold increase in glucose transfer from UDP-glucose to denatured substrates in HUGT1-transfected cells) and confirmed by reglucosylation assays in PMID:40267907. The IBA annotation is phylogenetically well-supported and represents the core function.
Reason: This is the core molecular function of UGGT1, well-established experimentally (PMID:10694380, PMID:40267907) and phylogenetically (IBA). UGGT1 is a glycosyltransferase family 24 member (CAZy GT24) that catalyzes the reglucosylation of N-glycans on misfolded glycoproteins as part of the ER quality control cycle.
Supporting Evidence:
PMID:10694380
Extracts from HUGT1-transfected cells displayed a 27-fold increase in the transfer of [(14)C]glucose from UDP-[(14)C]glucose to denatured substrates.
PMID:40267907
UGGT1 encodes UDP-glucose:glycoprotein glucosyltransferase 1, an enzyme critical for maintaining quality control of N-linked glycosylation.
GO:0005783 endoplasmic reticulum
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for ER localization. UGGT1 contains an N-terminal signal peptide and a C-terminal REEL ER-retrieval motif (UniProt). Arnold et al. (PMID:10694380) confirmed ER localization experimentally. This IBA is consistent with the more specific IEA annotation to ER lumen (GO:0005788). While GO:0005788 (ER lumen) is more precise, GO:0005783 (endoplasmic reticulum) is acceptable as a broader parent term and is correctly inferred phylogenetically.
Reason: UGGT1 is an established ER-resident protein. It contains the REEL ER retrieval signal (UniProt), and experimental localization was confirmed in PMID:10694380. The IBA annotation at this level is appropriate and consistent with more specific ER lumen and ERGIC annotations.
Supporting Evidence:
PMID:10694380
HUGT1 encodes a 1555 amino acid polypeptide that, upon cleavage of an N-terminal signal peptide, is predicted to produce a soluble 173 kDa protein with the ER retrieval signal REEL.
GO:0051082 unfolded protein binding
IBA
GO_REF:0000033
MARK AS OVER ANNOTATED
Summary: UGGT1 does interact with unfolded/misfolded glycoproteins, but this interaction represents substrate recognition for its glucosyltransferase enzymatic activity (GO:0003980), not an independent binding function. The N-terminal non-catalytic domain recognizes glycoproteins with minor folding defects (UniProt FUNCTION annotation, PMID:10694380), and this recognition is prerequisite to the catalytic reglucosylation step. This is analogous to how a kinase recognizes its protein substrates -- we would not annotate a kinase with "substrate protein binding" simply because it must bind substrates to phosphorylate them. The term GO:0051082 is also being obsoleted (go-ontology#30962). The IBA was propagated from experimental annotations on UGGT1 orthologs, but the underlying experimental evidence reflects the same substrate-recognition mechanism.
Reason: UGGT1 binding to unfolded proteins is incidental to its core enzymatic function as a UDP-glucose:glycoprotein glucosyltransferase. The protein recognizes misfolded glycoproteins as substrates for reglucosylation, not as an independent binding/chaperone function. As described in PMID:10694380, UGGT1 "operates as a gatekeeper for quality control by preventing transport of improperly folded glycoproteins out of the ER" through its glucosyltransferase activity -- the substrate recognition is integral to and subsumed by the enzymatic activity annotation GO:0003980. Additionally, GO:0051082 is being obsoleted per go-ontology#30962.
Supporting Evidence:
PMID:10694380
UDP-glucose:glycoprotein glucosyltransferase (UGT) is a soluble protein of the endoplasmic reticulum (ER) that operates as a gatekeeper for quality control by preventing transport of improperly folded glycoproteins out of the ER.
GO:0044322 endoplasmic reticulum quality control compartment
IEA
GO_REF:0000108
ACCEPT
Summary: IEA annotation placing UGGT1 in the ER quality control compartment (ERQC). The ERQC is defined as "a subcompartment of the endoplasmic reticulum in which proteins with improper or incorrect folding accumulate." UGGT1 is a central enzyme in this compartment, acting as the folding sensor that reglucosylates misfolded glycoproteins for re-engagement with calnexin/calreticulin (PMID:10694380, PMID:40267907). The Reactome pathway R-HSA-901032 explicitly places UGGT1 in the ERQC. This is an appropriate and informative localization annotation.
Reason: UGGT1 is a core component of the ERQC, functioning as the folding sensor that determines whether glycoproteins are retained for further folding attempts. Reactome R-HSA-901032 explicitly models UGGT1 in this compartment. The IEA annotation is well-supported by the known biology of UGGT1.
Supporting Evidence:
PMID:40267907
UGGT1 identifies and reglucosylates misfolded proteins, resulting in ER retention for re-binding to CNX/CRT to enable correct folding.
GO:0097359 UDP-glucosylation
IEA
GO_REF:0000108
ACCEPT
Summary: IEA annotation for the biological process of UDP-glucosylation. GO:0097359 is defined as "the covalent attachment of a UDP-glucose residue to a substrate molecule." This accurately describes the process UGGT1 catalyzes: transferring glucose from UDP-glucose to Man9GlcNAc2 N-glycans on misfolded glycoproteins. The annotation is logically inferred from the MF annotation GO:0003980 and is correct.
Reason: UDP-glucosylation is the direct process outcome of UGGT1's enzymatic activity. The annotation is correctly inferred from the molecular function GO:0003980 (UDP-glucose:glycoprotein glucosyltransferase activity). It accurately captures what UGGT1 does at the process level.
Supporting Evidence:
PMID:10694380
Extracts from HUGT1-transfected cells displayed a 27-fold increase in the transfer of [(14)C]glucose from UDP-[(14)C]glucose to denatured substrates.
GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity
IEA
GO_REF:0000120
ACCEPT
Summary: IEA annotation for UGGT1 glucosyltransferase activity from combined automated methods. This is a redundant annotation for the same GO term as the IBA and IDA annotations, but that is acceptable. The annotation correctly identifies UGGT1's core enzymatic function.
Reason: Correct assignment of the core molecular function. While redundant with the IBA and IDA annotations to GO:0003980, duplicate annotations with different evidence codes are acceptable.
Supporting Evidence:
PMID:10694380
Extracts from HUGT1-transfected cells displayed a 27-fold increase in the transfer of [(14)C]glucose from UDP-[(14)C]glucose to denatured substrates.
GO:0005788 endoplasmic reticulum lumen
IEA
GO_REF:0000044
ACCEPT
Summary: IEA annotation for ER lumen localization based on UniProt subcellular location mapping. UGGT1 is a soluble protein that resides in the ER lumen; it contains an N-terminal signal peptide (cleaved) and the C-terminal REEL ER retrieval signal (UniProt). Arnold et al. (PMID:10694380) confirmed ER localization. UniProt explicitly annotates SUBCELLULAR LOCATION as "Endoplasmic reticulum lumen." This is more specific than GO:0005783 and accurately captures where UGGT1 resides.
Reason: UGGT1 is a soluble, luminal ER protein. UniProt annotation with experimental evidence (PMID:10694380) and PROSITE ER-targeting motif (PRU10138) confirm ER lumen localization. This is the most appropriate CC annotation for UGGT1.
Supporting Evidence:
PMID:10694380
HUGT1 encodes a 1555 amino acid polypeptide that, upon cleavage of an N-terminal signal peptide, is predicted to produce a soluble 173 kDa protein with the ER retrieval signal REEL.
GO:0005793 endoplasmic reticulum-Golgi intermediate compartment
IEA
GO_REF:0000044
ACCEPT
Summary: IEA annotation for ERGIC localization based on UniProt subcellular location mapping. UniProt annotates UGGT1 SUBCELLULAR LOCATION as including "Endoplasmic reticulum-Golgi intermediate compartment" based on PROSITE and experimental evidence (PMID:10694380). UGGT1 cycles through the ERGIC as part of its ER retrieval mechanism, though its primary site of action is the ER lumen/ERQC. This is consistent with its ER retrieval signal (REEL) which would enable cycling through the ERGIC.
Reason: UniProt annotates UGGT1 to ERGIC, and an ISS annotation also supports this localization. UGGT1 contains the REEL retrieval signal which mediates cycling through the secretory pathway, consistent with ERGIC presence. While the primary functional site is the ER lumen, ERGIC presence is expected for ER-retrieved proteins.
Supporting Evidence:
PMID:10694380
HUGT1 encodes a 1555 amino acid polypeptide that, upon cleavage of an N-terminal signal peptide, is predicted to produce a soluble 173 kDa protein with the ER retrieval signal REEL.
GO:0009101 glycoprotein biosynthetic process
IEA
GO_REF:0000002
MODIFY
Summary: IEA annotation from InterPro mapping. GO:0009101 (glycoprotein biosynthetic process) is defined as "the chemical reactions and pathways resulting in the formation of glycoproteins." While UGGT1 does modify glycoproteins by adding glucose to their N-glycans, its role is in quality control and reglucosylation of already-formed glycoproteins, not in de novo glycoprotein biosynthesis. UGGT1 acts after the initial glycosylation and trimming steps, adding glucose back to N-glycans on misfolded proteins to retain them in the ER for refolding. This is better described as protein N-linked glycosylation (GO:0006487) or more specifically the ERQC pathway, rather than glycoprotein biosynthesis per se.
Reason: UGGT1 does not participate in de novo glycoprotein biosynthesis. It acts downstream in the quality control cycle, reglucosylating N-glycans on misfolded glycoproteins that have already been synthesized and initially glycosylated. The IBA annotation to GO:0018279 (protein N-linked glycosylation via asparagine) is a more appropriate process term, and GO:0006487 (protein N-linked glycosylation) would also be suitable. GO:0009101 is misleading because UGGT1 does not contribute to glycoprotein biosynthesis in the usual sense.
Proposed replacements: protein N-linked glycosylation
GO:0016740 transferase activity
IEA
GO_REF:0000043
ACCEPT
Summary: IEA annotation from UniProt keyword mapping for the broad parent term "transferase activity." UGGT1 is indeed a transferase (it transfers glucose from UDP-glucose to glycoprotein substrates). However, the more specific term GO:0003980 (UDP-glucose:glycoprotein glucosyltransferase activity) is already annotated via IBA, IDA, and other IEA sources. GO:0016740 is a very broad ancestral term that adds no information beyond what GO:0003980 provides.
Reason: While extremely broad, this IEA annotation is not incorrect. UGGT1 is a transferase. The more specific child term GO:0003980 is already captured by IBA and IDA annotations. It is acceptable for IEA annotations to be broader than what is determined by IBA or literature.
GO:0016757 glycosyltransferase activity
IEA
GO_REF:0000043
ACCEPT
Summary: IEA annotation from UniProt keyword mapping for "glycosyltransferase activity." UGGT1 is a member of glycosyltransferase family 24 (CAZy GT24) and is classified as such in UniProt. This is a parent term of GO:0003980. While less specific than GO:0003980, it is correct and acceptable as an IEA annotation.
Reason: Correct parent term annotation. UGGT1 belongs to CAZy GT24 and is a glycosyltransferase by classification (UniProt KW-0328). The more specific GO:0003980 is already annotated. Broader IEA annotations are acceptable.
GO:1904380 endoplasmic reticulum mannose trimming
IEA
GO_REF:0000117
REMOVE
Summary: IEA annotation from ARBA machine learning. GO:1904380 is defined as "any protein alpha-1,2-demannosylation that takes place in the endoplasmic reticulum quality control compartment (ERQC)." UGGT1 is NOT a mannosidase and does NOT trim mannose residues. UGGT1 is a glucosyltransferase that adds glucose to N-glycans. Mannose trimming in the ERQC is carried out by ER mannosidase I (MAN1B1) and EDEM family members (PMID:40267907). This annotation is incorrect and was likely mis-assigned by the ARBA model.
Reason: UGGT1 does not perform mannose trimming. It is a glucosyltransferase that adds glucose to Man9GlcNAc2 N-glycans on misfolded glycoproteins. Mannose trimming is carried out by distinct enzymes (ERManI/MAN1B1, EDEM1/2/3) that act in the ERQC pathway. While UGGT1 operates in the same pathway as the mannose trimming enzymes, it performs an entirely different enzymatic reaction (glucosylation, not demannosylation). This is an incorrect ARBA prediction.
Supporting Evidence:
PMID:40267907
A molecular marking system involving multiple ER-resident exo-mannosidases, including ER mannosidase I (ERManI) and EDEM family members, operates in tandem with this cyclical process by progressively trimming mannose residues from glycoproteins.
GO:0005515 protein binding
IPI
PMID:17353931
Large-scale mapping of human protein-protein interactions by...
REMOVE
Summary: IPI annotation for "protein binding" from a large-scale IP-MS study (PMID:17353931, Ewing et al. 2007). This study mapped protein-protein interactions for 338 bait proteins using immunoprecipitation followed by mass spectrometry. UGGT1 was identified as a prey in this screen, but the study does not provide specific information about the biological significance of the interaction. The term "protein binding" (GO:0005515) is uninformative and does not tell us anything about UGGT1's actual function.
Reason: Per curation guidelines, "protein binding" (GO:0005515) should be avoided as it provides no information about the actual molecular function. This annotation comes from a large-scale proteomics screen (PMID:17353931) that does not provide insight into the specific nature of the interaction. UGGT1 is known to interact with SELENOF (PMID:24415556) and METTL23 (PMID:23349634), but these are better captured by specific interaction annotations rather than the uninformative "protein binding" term.
GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity
IDA
PMID:40267907
Bi-allelic UGGT1 variants cause a congenital disorder of gly...
ACCEPT
Summary: IDA annotation for UGGT1 glucosyltransferase activity from Dardas et al. 2025 (PMID:40267907). This study identified bi-allelic UGGT1 variants causing a congenital disorder of glycosylation (UGGT1-CDG). The authors performed both cellular reglucosylation assays and in vitro catalytic activity assays using HPLC-based quantification of glucose transfer. Pathogenic UGGT1 variants were shown to impair glucosylation and catalytic activity, providing direct evidence for UGGT1 as a UDP-glucose:glycoprotein glucosyltransferase.
Reason: Strong experimental evidence from direct enzymatic assays. Dardas et al. (PMID:40267907) used both cellular reglucosylation assays (calreticulin pull-down) and in vitro catalytic activity assays (HPLC-based glucose transfer quantification) to demonstrate UGGT1 glucosyltransferase activity. Pathogenic variants showed impaired activity, confirming the enzymatic function.
Supporting Evidence:
PMID:40267907
Molecular studies showed that pathogenic UGGT1 variants impair UGGT1 glucosylation and catalytic activity, disrupt mRNA splicing, or inhibit endoplasmic reticulum (ER) retention.
GO:1904380 endoplasmic reticulum mannose trimming
TAS
Reactome:R-HSA-901032
REMOVE
Summary: TAS annotation from Reactome pathway R-HSA-901032 (ER Quality Control Compartment). UGGT1 is correctly placed in the ERQC pathway by Reactome, but GO:1904380 (ER mannose trimming) specifically describes alpha-1,2-demannosylation. UGGT1 does not trim mannose; it adds glucose. UGGT1 operates in the same quality control pathway as the mannose-trimming enzymes but performs a distinct reaction (reglucosylation). This annotation is incorrect -- UGGT1 was likely erroneously associated with this process term because it is part of the broader ERQC pathway that includes mannose trimming steps.
Reason: UGGT1 does not perform mannose trimming. GO:1904380 is defined as "any protein alpha-1,2-demannosylation that takes place in the ERQC." UGGT1 is a glucosyltransferase, not a mannosidase. While UGGT1 participates in the ERQC pathway alongside mannose-trimming enzymes, it catalyzes the opposite modification: adding glucose rather than removing mannose. This annotation appears to be a mis-mapping from the Reactome ERQC pathway.
Supporting Evidence:
PMID:40267907
A molecular marking system involving multiple ER-resident exo-mannosidases, including ER mannosidase I (ERManI) and EDEM family members, operates in tandem with this cyclical process by progressively trimming mannose residues from glycoproteins. This stepwise de-mannosylation eventually reduces the affinity of UGGT1 for its substrate, preventing further reglucosylation and facilitating the extraction of misfolded proteins from the CNX cycle
GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity
TAS
Reactome:R-HSA-548884
ACCEPT
Summary: TAS annotation from Reactome reaction R-HSA-548884 which models UGGT1/2 transferring glucose from dolichyl beta-D-glucosyl phosphate to unfolded protein glycans. The Reactome entry states that "UGGT1 and 2 are able to distinguish proteins with minor folding defects in the ERQC and reglucosylate them." This correctly captures the core enzymatic function of UGGT1.
Reason: Correctly annotated from a well-curated Reactome reaction that specifically models the UGGT1 glucosyltransferase reaction. Consistent with all other evidence for GO:0003980.
Supporting Evidence:
Reactome:R-HSA-548884
The UDP-glucose:glycoprotein glucosyltransferases 1 and 2 (UGGT1 and 2) are able to distinguish proteins with minor folding defects in the ERQC and reglucosylate them, by transferring a glucose (from dolichyl beta-D-glucosyl phosphate, DbGP) onto the alpha 1,3 mannose of the b (or c, not shown here) branch
GO:0005515 protein binding
IPI
PMID:23349634
A newly uncovered group of distantly related lysine methyltr...
REMOVE
Summary: IPI annotation for protein binding from Cloutier et al. 2013 (PMID:23349634). This study identified UGGT1 as an interactor of METTL23, a lysine methyltransferase, by affinity purification coupled to mass spectrometry. UniProt confirms "Interacts with METTL23" (PMID:23349634). The interaction was identified in the context of a study showing METTL23 preferentially associates with molecular chaperones. While the interaction is real, the term "protein binding" is uninformative.
Reason: Per curation guidelines, "protein binding" (GO:0005515) is uninformative and should be avoided. The underlying data shows UGGT1 interacts with METTL23 (a lysine methyltransferase) but this does not inform us about UGGT1's molecular function. The interaction may reflect METTL23's role in regulating chaperone/quality-control machinery rather than a core function of UGGT1.
Supporting Evidence:
PMID:23349634
A common theme for most of these putative methyltransferases' interactors was chaperones, be they of the Hsp70 or Hsp90 variety (see METTL18, CAMKMT, METTL21C, METTL22, METTL23, METTL21A, and METTL21B)
GO:0032991 protein-containing complex
IDA
PMID:23349634
A newly uncovered group of distantly related lysine methyltr...
KEEP AS NON CORE
Summary: IDA annotation for "protein-containing complex" from Cloutier et al. 2013 (PMID:23349634). This study showed UGGT1 interacts with METTL23 by AP-MS. Additionally, UniProt notes that UGGT1 forms a tight complex with SELENOF (PMID:24415556) and is part of a large chaperone multiprotein complex comprising DNAJB11, HSP90B1, HSPA5, HYOU, PDIA2, PDIA4, PDIA6, PPIB, SDF2L1, and UGGT1 (by similarity from UniProtKB:Q9JLA3). The term GO:0032991 is very generic -- it simply indicates the protein is found in some complex. While technically correct, it is not very informative.
Reason: UGGT1 is part of protein complexes (with SELENOF, with METTL23, and as part of a larger ER chaperone complex), so the annotation is not wrong. However, GO:0032991 is a very generic CC term. Participation in protein complexes is not a core defining feature of UGGT1 -- its core function is its glucosyltransferase enzymatic activity. The SELENOF complex enhances UGGT1 activity (PMID:24415556) but this is regulatory, not a core localization.
Supporting Evidence:
PMID:23349634
A common theme for most of these putative methyltransferases' interactors was chaperones, be they of the Hsp70 or Hsp90 variety (see METTL18, CAMKMT, METTL21C, METTL22, METTL23, METTL21A, and METTL21B)
GO:0005515 protein binding
IPI
PMID:26808496
Comparative Proteomics Reveals Important Viral-Host Interact...
REMOVE
Summary: IPI annotation for protein binding from Liu et al. 2016 (PMID:26808496). This study used affinity purification of HCV E2 protein complexes from HCV-infected human hepatoma cells and identified UGGT1 (referred to as UGT1) as a novel E2 binding partner. The interaction was validated and shown to be functionally relevant: "gene silencing of UGT1 in human hepatoma cell line Huh7.5.1 markedly decreased the production of infectious HCV, indicating a regulatory role of UGT1 in viral lifecycle." While this is an interesting finding about UGGT1's role in the HCV lifecycle, the "protein binding" term is uninformative and this interaction reflects UGGT1's normal ER quality control function on the viral glycoprotein E2.
Reason: Per curation guidelines, "protein binding" (GO:0005515) is uninformative. The interaction between UGGT1 and HCV E2 likely reflects UGGT1's normal role in glycoprotein quality control -- HCV E2 is a heavily glycosylated ER protein that would be subject to UGGT1's quality control function. This is not a novel molecular function of UGGT1 but rather evidence that UGGT1's normal glucosyltransferase activity acts on viral glycoproteins as substrates.
Supporting Evidence:
PMID:26808496
85 cellular proteins and three viral proteins were successfully identified in three independent trials, among which alphafetoprotein (AFP), UDP-glucose: glycoprotein glucosyltransferase 1 (UGT1) and HCV NS4B were further validated as novel E2 binding partners.
GO:0070062 extracellular exosome
HDA
PMID:19199708
Proteomic analysis of human parotid gland exosomes by multid...
MARK AS OVER ANNOTATED
Summary: HDA annotation for extracellular exosome localization from a proteomic analysis of human parotid gland exosomes (PMID:19199708). UGGT1 (referred to as "UDP-glucose ceramide glucosyltransferase-like 1 isoform 1") was identified among 491 proteins in the exosome fraction of parotid saliva by MudPIT mass spectrometry. However, the authors note that parotid exosomes "lacked endoplasmic reticulum or nuclear resident proteins," suggesting ER-resident proteins should not normally be present in exosomes. UGGT1 is an ER-resident protein with a strong ER retention signal (REEL), making its presence in exosomes likely a contaminant or artifact of the proteomics approach.
Reason: UGGT1 is an established ER-resident protein with a strong ER retrieval signal (REEL). Its detection in exosomes from parotid gland saliva (PMID:19199708) most likely represents contamination or low-level leakage rather than true exosomal localization. The authors themselves note that ER-resident proteins should not be present in true exosomes. High-throughput proteomics of exosome fractions frequently identify ER contaminants. Extracellular exosome is not a meaningful localization for UGGT1.
Supporting Evidence:
PMID:19199708
we found that parotid exosomes lacked endoplasmic reticulum or nuclear resident proteins, distinguishing them from apoptotic bodies or shed membranes 19 , 22 , 31
GO:0005788 endoplasmic reticulum lumen
TAS
Reactome:R-HSA-548884
ACCEPT
Summary: TAS annotation for ER lumen localization from Reactome reaction R-HSA-548884. UGGT1 is modeled in Reactome as a soluble ER lumen protein that catalyzes the reglucosylation of misfolded glycoproteins. This is consistent with UniProt's annotation of SUBCELLULAR LOCATION as "Endoplasmic reticulum lumen" and with the experimental evidence from PMID:10694380 showing ER localization and the presence of an ER retrieval signal (REEL).
Reason: UGGT1 is a well-established ER lumen protein. Reactome correctly places it in the ER lumen for its reglucosylation reaction. Consistent with the IEA annotation from UniProt and experimental evidence (PMID:10694380).
Supporting Evidence:
PMID:10694380
HUGT1 encodes a 1555 amino acid polypeptide that, upon cleavage of an N-terminal signal peptide, is predicted to produce a soluble 173 kDa protein with the ER retrieval signal REEL.
GO:0005793 endoplasmic reticulum-Golgi intermediate compartment
ISS
GO_REF:0000024
ACCEPT
Summary: ISS annotation for ERGIC localization transferred from experimentally-verified orthologs by curator judgment. UniProt annotates UGGT1 to the ERGIC based on both PROSITE ER-targeting rules and experimental evidence (PMID:10694380). The ISS annotation is consistent with the IEA annotation to the same term and with the known biology of UGGT1 as a protein that cycles through the early secretory pathway via its REEL retrieval signal.
Reason: Consistent with the IEA annotation and UniProt subcellular location data. UGGT1 contains the REEL retrieval signal enabling cycling through the ERGIC. The ISS transfer from orthologs is well-supported.
Supporting Evidence:
PMID:10694380
HUGT1 encodes a 1555 amino acid polypeptide that, upon cleavage of an N-terminal signal peptide, is predicted to produce a soluble 173 kDa protein with the ER retrieval signal REEL.
GO:0051082 unfolded protein binding
IDA
PMID:10694380
Two homologues encoding human UDP-glucose:glycoprotein gluco...
MARK AS OVER ANNOTATED
Summary: The IDA annotation to GO:0051082 from PMID:10694380 reflects the experimental observation that UGGT1 selectively recognizes and acts upon misfolded/unfolded glycoproteins. Arnold et al. (2000) demonstrated that HUGT1 (UGGT1) extracts show a 27-fold increase in transfer of [14C]glucose from UDP-[14C]glucose to denatured substrates. The assay measured glucosyltransferase activity toward denatured substrates, not an independent binding activity. UGGT1's interaction with unfolded glycoproteins is substrate recognition intrinsic to its glucosyltransferase catalytic cycle: the N-terminal domain senses folding defects, and the C-terminal catalytic domain then reglucosylates the substrate. UniProt describes the FUNCTION as "Recognizes glycoproteins with minor folding defects. Reglucosylates single N-glycans near the misfolded part of the protein." This is an enzymatic activity, not a standalone binding function. The term GO:0051082 is also being obsoleted (go-ontology#30962).
Reason: The experimental evidence in PMID:10694380 demonstrates glucosyltransferase activity (glucose transfer to denatured substrates), which inherently requires substrate recognition/binding. Annotating this as "unfolded protein binding" separately from the glucosyltransferase activity is an over-annotation -- it conflates enzymatic substrate recognition with an independent molecular function. UGGT1 is not a chaperone that simply binds and holds unfolded proteins; it is an enzyme that recognizes misfolded glycoprotein substrates and catalytically reglucosylates them. The core molecular function is fully captured by GO:0003980 (UDP-glucose:glycoprotein glucosyltransferase activity). Furthermore, GO:0051082 is being obsoleted per go-ontology#30962.
Supporting Evidence:
PMID:10694380
UDP-glucose:glycoprotein glucosyltransferase (UGT) is a soluble protein of the endoplasmic reticulum (ER) that operates as a gatekeeper for quality control by preventing transport of improperly folded glycoproteins out of the ER.
PMID:10694380
Extracts from HUGT1-transfected cells displayed a 27-fold increase in the transfer of [(14)C]glucose from UDP-[(14)C]glucose to denatured substrates.
GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity
IDA
PMID:10694380
Two homologues encoding human UDP-glucose:glycoprotein gluco...
ACCEPT
Summary: IDA annotation for the core enzymatic activity from the foundational characterization paper by Arnold et al. 2000 (PMID:10694380). This study cloned HUGT1 (UGGT1), expressed it in COS-1 cells, and demonstrated a 27-fold increase in glucose transfer from UDP-glucose to denatured glycoprotein substrates. Site-directed mutagenesis of highly conserved residues (D1452A, Q1453A, D1454A, L1455A, P1456A, N1457A) in the catalytic domain identified four residues essential for catalytic function. This is the primary experimental evidence establishing UGGT1 as a UDP-glucose:glycoprotein glucosyltransferase.
Reason: Foundational direct assay evidence for UGGT1's core molecular function. Arnold et al. (PMID:10694380) performed definitive enzymatic assays (radiolabeled glucose transfer) and site-directed mutagenesis confirming the glucosyltransferase activity. This is the gold-standard IDA evidence.
Supporting Evidence:
PMID:10694380
Extracts from HUGT1-transfected cells displayed a 27-fold increase in the transfer of [(14)C]glucose from UDP-[(14)C]glucose to denatured substrates.
PMID:10694380
Site-directed alanine mutagenesis within a highly conserved region of HUGT1 identified four residues that are essential for catalytic function.
GO:0005783 endoplasmic reticulum
IDA
PMID:10694380
Two homologues encoding human UDP-glucose:glycoprotein gluco...
ACCEPT
Summary: IDA annotation for ER localization from Arnold et al. 2000 (PMID:10694380). The study showed that UGGT1 (HUGT1) is localized to the ER, consistent with its signal peptide, ER retrieval signal (REEL), and function as an ER-resident quality control enzyme. The study expressed HUGT1 in COS-1 cells and obtained protein localized to the ER for enzymatic activity assays.
Reason: Direct experimental evidence of ER localization from the characterization study (PMID:10694380). The more specific GO:0005788 (ER lumen) is also annotated, but GO:0005783 is acceptable as the parent term confirmed by this IDA.
Supporting Evidence:
PMID:10694380
HUGT1 encodes a 1555 amino acid polypeptide that, upon cleavage of an N-terminal signal peptide, is predicted to produce a soluble 173 kDa protein with the ER retrieval signal REEL.
GO:0051084 'de novo' post-translational protein folding
TAS
PMID:10694380
Two homologues encoding human UDP-glucose:glycoprotein gluco...
MODIFY
Summary: TAS annotation for "de novo post-translational protein folding" (GO:0051084), defined as "the process of assisting in the correct noncovalent folding of newly formed polypeptides or folding intermediates." UGGT1 does participate in the protein folding quality control cycle by reglucosylating misfolded glycoproteins so they can re-engage with calnexin/calreticulin for further folding attempts (PMID:10694380, PMID:40267907). However, UGGT1 itself is not a chaperone that directly assists in protein folding. It is an enzyme that tags misfolded proteins for re-entry into the calnexin/calreticulin chaperone cycle. The term implies direct folding assistance, which is misleading for UGGT1. A more accurate process annotation would be one reflecting its role in protein quality control in the ER or N-linked glycosylation.
Reason: UGGT1 does not directly fold proteins. It is an enzyme (glucosyltransferase) that acts as a folding sensor, recognizing misfolded glycoproteins and reglucosylating them so they can re-bind calnexin/calreticulin for another round of folding. The actual folding is performed by the calnexin/calreticulin chaperone system. "De novo post-translational protein folding" implies direct chaperone activity, which is inaccurate for UGGT1. A better process term would be GO:0006487 (protein N-linked glycosylation) or GO:0097359 (UDP-glucosylation), which more accurately reflect UGGT1's enzymatic role in the quality control cycle.
Proposed replacements: protein N-linked glycosylation
Supporting Evidence:
PMID:40267907
UGGT1 identifies and reglucosylates misfolded proteins, resulting in ER retention for re-binding to CNX/CRT to enable correct folding.
PMID:10694380
UDP-glucose:glycoprotein glucosyltransferase (UGT) is a soluble protein of the endoplasmic reticulum (ER) that operates as a gatekeeper for quality control by preventing transport of improperly folded glycoproteins out of the ER.

Core Functions

UGGT1 catalyzes the reglucosylation of N-glycans on misfolded glycoproteins in the ER lumen, serving as the central folding sensor and checkpoint of the calnexin/calreticulin quality control cycle. Its seven-domain architecture (TRXL1-4, betaS1-2, GT24 catalytic domain) provides interdomain conformational flexibility that enables recognition of diverse molten-globule-like folding intermediates and glucosylation of glycans at variable distances from misfolded regions (DOI:10.1073/pnas.1703682114). UGGT1 writes a site-selective "glyco-code" that programs which ER chaperones engage substrates at specific glycosylation sites (DOI:10.1016/j.molcel.2023.11.006). This reglucosylation competes with EDEM-family mannose trimming in a "tug-of-war" that determines substrate fate between refolding and ERAD commitment (DOI:10.1101/2023.10.18.562958). UGGT1 also promotes substrate solubility by maintaining misfolded glycoproteins in the lectin-chaperone cycle, reducing insoluble aggregation (DOI:10.1091/mbc.e13-02-0101). Activity is modulated by the partner selenoprotein SELENOF/SEP15, which affects a subset of UGGT1 clients (DOI:10.1073/pnas.2315009121).

Supporting Evidence:
  • PMID:10694380
    Extracts from HUGT1-transfected cells displayed a 27-fold increase in the transfer of [(14)C]glucose from UDP-[(14)C]glucose to denatured substrates.
  • PMID:40267907
    Molecular studies showed that pathogenic UGGT1 variants impair UGGT1 glucosylation and catalytic activity, disrupt mRNA splicing, or inhibit endoplasmic reticulum (ER) retention.

References

Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Automatic assignment of GO terms using logical inference, based on on inter-ontology links
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods
Two homologues encoding human UDP-glucose:glycoprotein glucosyltransferase differ in mRNA expression and enzymatic activity.
Large-scale mapping of human protein-protein interactions by mass spectrometry.
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).
A newly uncovered group of distantly related lysine methyltransferases preferentially interact with molecular chaperones to regulate their activity.
Both isoforms of human UDP-glucose:glycoprotein glucosyltransferase are enzymatically active.
Comparative Proteomics Reveals Important Viral-Host Interactions in HCV-Infected Human Liver Cells.
Bi-allelic UGGT1 variants cause a congenital disorder of glycosylation.
Reactome:R-HSA-548884
UGGT1,2 transfers glucose from DbGP to (un)folded protein:(GlcNAc)2 (Man)8b
Reactome:R-HSA-901032
ER Quality Control Compartment (ERQC)
DOI:10.1073/pnas.1703682114
Interdomain conformational flexibility underpins the activity of UGGT, the eukaryotic glycoprotein secretion checkpoint.
  • UGGT1 has a seven-domain topology with four N-terminal thioredoxin-like domains (TRXL1-4) arranged in an arc, two beta-sandwich domains, and a C-terminal GT24 catalytic domain
  • Interdomain conformational flexibility is required for activity; engineered interdomain disulfides that rigidify UGGT reduce catalytic function
DOI:10.1016/j.molcel.2023.11.006
ER chaperones use a protein folding and quality control glyco-code.
  • UGGT1-mediated reglucosylation writes a programmable glyco-code that determines which ER chaperones engage substrates at specific glycosylation sites
  • UGGT1 deletion reduces monoglucosylated AAT by more than half; UGGT1/2 double deletion abolishes glucosylation
  • UGGT preferentially modifies particular glycosylation sites (e.g., AAT N247 more than N83), supporting positional logic in the glyco-code
DOI:10.1101/2023.10.18.562958
UGGT1-mediated reglucosylation of N-glycan competes with ER-associated degradation of unstable and misfolded glycoproteins.
  • UGGT1 delays degradation of misfolded glycoproteins in a tug-of-war between reglucosylation/refolding and EDEM-mediated mannose trimming that commits substrates to ERAD
  • UGGT2 protein levels are ~6.9% (HCT116) and ~29.8% (HeLa) of UGGT1, establishing UGGT1 as the dominant mammalian reglucosyltransferase
DOI:10.1073/pnas.2315009121
Insights into the interaction between UGGT, the gatekeeper of folding in the ER, and its partner, the selenoprotein SEP15.
  • AlphaFold-multimer predicts a specific UGGT1/SEP15 complex with SEP15 selenocysteine positioned proximal to UGGT1 catalytic region
  • About 27% of expressed SEP15 co-occurs with UGGT1; interface mutants reduce binding to ~3.8-6.5%
  • SEP15 affects a subset of UGGT1 clients rather than globally shifting all UGGT activity (26 proteins with significantly altered glucosylation in SELENOF-null cells)
DOI:10.1091/mbc.e13-02-0101
UDP-glucose:glycoprotein glucosyltransferase (UGGT1) promotes substrate solubility in the endoplasmic reticulum.
  • UGGT1 enzymatic activity increases the soluble fraction of misfolded alpha-1 antitrypsin variants and reduces insoluble aggregation, maintaining ER solubility of folding intermediates through monoglucosylation and lectin-chaperone cycling
DOI:10.7554/eLife.63997
Quantitative glycoproteomics reveals cellular substrate selectivity of the ER protein quality control sensors UGGT1 and UGGT2.
  • UGGT1 preferentially modifies large, complex glycoproteins (often membrane/plasma-membrane targeted), while UGGT2 preferentially modifies smaller soluble/lysosomal proteins

📚 Additional Documentation

Deep Research Falcon

(UGGT1-deep-research-falcon.md)

provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-20T15:26:08.012326'
end_time: '2026-02-20T15:39:31.055797'
duration_seconds: 803.04
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: UGGT1
gene_symbol: UGGT1
uniprot_accession: Q9NYU2
protein_description: 'RecName: Full=UDP-glucose:glycoprotein glucosyltransferase
1; Short=UGT1; Short=hUGT1; EC=2.4.1.- {ECO:0000269|PubMed:24415556}; AltName:
Full=UDP--Glc:glycoprotein glucosyltransferase; AltName: Full=UDP-glucose ceramide
glucosyltransferase-like 1; Flags: Precursor;'
gene_info: Name=UGGT1; Synonyms=GT, UGCGL1, UGGT, UGT1 {ECO:0000303|PubMed:10694380},
UGTR {ECO:0000250|UniProtKB:Q9JLA3};
organism_full: Homo sapiens (Human).
protein_family: Belongs to the glycosyltransferase 8 family.
protein_domains: Glyco_transf_24. (IPR040497); Nucleotide-diphossugar_trans. (IPR029044);
UDP-g_GGtrans. (IPR009448); UGGT_TRXL_1. (IPR040693); UGGT_TRXL_2. (IPR040694)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 37


Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

  • UniProt Accession: Q9NYU2
  • Protein Description: RecName: Full=UDP-glucose:glycoprotein glucosyltransferase 1; Short=UGT1; Short=hUGT1; EC=2.4.1.- {ECO:0000269|PubMed:24415556}; AltName: Full=UDP--Glc:glycoprotein glucosyltransferase; AltName: Full=UDP-glucose ceramide glucosyltransferase-like 1; Flags: Precursor;
  • Gene Information: Name=UGGT1; Synonyms=GT, UGCGL1, UGGT, UGT1 {ECO:0000303|PubMed:10694380}, UGTR {ECO:0000250|UniProtKB:Q9JLA3};
  • Organism (full): Homo sapiens (Human).
  • Protein Family: Belongs to the glycosyltransferase 8 family.
  • Key Domains: Glyco_transf_24. (IPR040497); Nucleotide-diphossugar_trans. (IPR029044); UDP-g_GGtrans. (IPR009448); UGGT_TRXL_1. (IPR040693); UGGT_TRXL_2. (IPR040694)

MANDATORY VERIFICATION STEPS:

  1. Check if the gene symbol "UGGT1" matches the protein description above
  2. Verify the organism is correct: Homo sapiens (Human).
  3. Check if protein family/domains align with what you find in literature
  4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'UGGT1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene UGGT1 (gene ID: UGGT1, UniProt: Q9NYU2) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

  • UniProt Accession: Q9NYU2
  • Protein Description: RecName: Full=UDP-glucose:glycoprotein glucosyltransferase 1; Short=UGT1; Short=hUGT1; EC=2.4.1.- {ECO:0000269|PubMed:24415556}; AltName: Full=UDP--Glc:glycoprotein glucosyltransferase; AltName: Full=UDP-glucose ceramide glucosyltransferase-like 1; Flags: Precursor;
  • Gene Information: Name=UGGT1; Synonyms=GT, UGCGL1, UGGT, UGT1 {ECO:0000303|PubMed:10694380}, UGTR {ECO:0000250|UniProtKB:Q9JLA3};
  • Organism (full): Homo sapiens (Human).
  • Protein Family: Belongs to the glycosyltransferase 8 family.
  • Key Domains: Glyco_transf_24. (IPR040497); Nucleotide-diphossugar_trans. (IPR029044); UDP-g_GGtrans. (IPR009448); UGGT_TRXL_1. (IPR040693); UGGT_TRXL_2. (IPR040694)

MANDATORY VERIFICATION STEPS:

  1. Check if the gene symbol "UGGT1" matches the protein description above
  2. Verify the organism is correct: Homo sapiens (Human).
  3. Check if protein family/domains align with what you find in literature
  4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'UGGT1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene UGGT1 (gene ID: UGGT1, UniProt: Q9NYU2) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Title: Functional Annotation Research Report — Human UGGT1 (UniProt Q9NYU2)

Publication window emphasis: 2023–2024 where available; foundational work included for mechanistic completeness.

  1. Executive summary

UDP-glucose:glycoprotein glucosyltransferase 1 (UGGT1; UniProt Q9NYU2) is a soluble, luminal endoplasmic reticulum (ER) glycosyltransferase that acts as a folding sensor (quality-control checkpoint) for N-glycosylated secretory and membrane proteins by transferring a glucose from UDP-glucose onto deglucosylated high-mannose N-glycans on non-native substrates (“reglucosylation”), thereby regenerating the monoglucosylated glycan signal that recruits the lectin chaperones calnexin (CNX) and calreticulin (CRT). (suzuki2021foldingandquality pages 9-10, roversi2017interdomainconformationalflexibility pages 1-2, adams2020quantitativeglycoproteomicsreveals pages 1-4)

Across recent studies, UGGT1 emerges as (i) the dominant mammalian reglucosyltransferase that “writes” a site- and time-dependent “glyco-code” controlling lectin-chaperone engagement (2023), (ii) a factor that delays mannose-trimming–dependent ER-associated degradation (ERAD) in a “tug-of-war” between refolding and disposal (2024), and (iii) a protein whose substrate selection can be modulated by the UGGT1 partner selenoprotein SEP15/SELENOF via a defined binding interface supported by AlphaFold-multimer predictions and validated by co-IP and glycoproteomics (2024). (guay2023erchaperonesuse pages 8-10, ninagawa2024uggt1mediatedreglucosylationof pages 1-5, williams2024insightsintothe pages 5-6)

  1. Target identity verification (critical disambiguation)

UGGT1 (Q9NYU2) is the ER quality-control “UDP-glucose:glycoprotein glucosyltransferase” that modifies N-linked glycans of glycoproteins; it is not a member of the drug-metabolizing UDP-glucuronosyltransferase UGT1A locus, nor a glycolipid glucosyltransferase. The literature summarized here explicitly defines UGGT1 as an ER luminal folding checkpoint enzyme acting in the CNX/CRT cycle through N-glycan reglucosylation, consistent with UniProt’s enzyme description and domain family assignment. (roversi2017interdomainconformationalflexibility pages 1-2, takeda2016effectsofdomain pages 1-2, adams2020quantitativeglycoproteomicsreveals pages 1-4)

  1. Key concepts and definitions (current understanding)

3.1 The calnexin/calreticulin cycle and “reglucosylation”

Newly synthesized N-glycoproteins in the ER carry N-glycans that are processed to monoglucosylated forms that bind CNX/CRT; after deglucosylation (e.g., by glucosidase II), substrates release from CNX/CRT. UGGT1 functions as a checkpoint by re-adding a glucose onto the N-glycan of incompletely folded proteins, restoring lectin binding and retaining clients in the ER for additional folding attempts. This cycle is schematized in a structural review figure (Figure depicting UGGT and glucosidase II roles), which captures the conceptual flow of trimming → lectin binding → deglucosylation → UGGT-mediated re-entry. (kozlov2020calnexincycle– media d42ce2c5, roversi2017interdomainconformationalflexibility pages 1-2)

3.2 Enzymatic reaction and substrates

Reaction (physiologic): UGGT1 transfers glucose from UDP-glucose to N-linked high-mannose glycans on non-native glycoproteins, generating monoglucosylated N-glycans that are recognized by CNX/CRT. (suzuki2021foldingandquality pages 9-10, roversi2017interdomainconformationalflexibility pages 1-2, takeda2016effectsofdomain pages 1-2)

Donor: UDP-glucose. (roversi2017interdomainconformationalflexibility pages 1-2, takeda2016effectsofdomain pages 1-2)

Acceptors: deglucosylated high-mannose N-glycans on incompletely folded glycoproteins; UGGT recognition is tied to protein conformational state rather than strict primary sequence. (suzuki2021foldingandquality pages 9-10, adams2020quantitativeglycoproteomicsreveals pages 1-4)

3.3 Substrate recognition principles (“folding sensor” behavior)

UGGT1 preferentially recognizes partially structured, molten-globule-like clients and is inactive toward fully folded or completely unfolded proteins, consistent with a role in identifying near-native folding intermediates rather than terminally unfolded chains. (suzuki2021foldingandquality pages 9-10)

Recognition involves exposed hydrophobic regions of the polypeptide (a structural hallmark of non-native states) and glycan features (e.g., likely involvement of the innermost GlcNAc), and UGGT can sense local folding defects in otherwise folded proteins. (suzuki2021foldingandquality pages 9-10, adams2020quantitativeglycoproteomicsreveals pages 1-4)

Spatial reach: UGGT can glucosylate N-glycans at least ~40 Å away from a localized disordered region, supporting a model where UGGT bridges a misfold “sensor” site and a separate glycan “writer” site. (suzuki2021foldingandquality pages 9-10)

  1. Protein features: localization, domain architecture, and structure–function

4.1 Subcellular localization

UGGT is a large, soluble ER-resident protein with a C-terminal KDEL-like retrieval sequence, consistent with ER luminal residency and retrieval. (suzuki2021foldingandquality pages 9-10)

Beyond the ER, immunolocalization evidence indicates UGGT can also be found in the ER–Golgi intermediate compartment (ERGIC), consistent with ER/early secretory pathway surveillance. (suzuki2021foldingandquality pages 9-10, takeda2016effectsofdomain pages 1-2)

4.2 Domain architecture (folding-sensor + catalytic “writer” modules)

UGGT has a multi-domain architecture in which the catalytic activity resides in the C-terminal portion (~20% of the protein) corresponding to a GT family 24 catalytic domain, while N-terminal regions contribute to folding sensing and substrate engagement. (suzuki2021foldingandquality pages 9-10, takeda2016effectsofdomain pages 1-2)

Structural studies describe a seven-domain topology: four N-terminal thioredoxin-like domains (TRXL1–TRXL4) arranged in an arc, followed by two seven-stranded β-sandwich domains (βS1, βS2) that clasp the C-terminal glucosyltransferase (GT) domain. (roversi2017interdomainconformationalflexibility pages 1-2, roversi2017interdomainconformationalflexibility pages 2-2)

4.3 Structural basis for promiscuity and checkpoint activity

A cryo-EM reconstruction at ~15 Å and crystallography show substantial interdomain conformational flexibility in the TRXL region; engineered interdomain disulfides that rigidify UGGT reduce activity, supporting the hypothesis that flexibility enables UGGT to accommodate diverse client shapes and to position its catalytic domain relative to glycans at variable distances from misfolds. (roversi2017interdomainconformationalflexibility pages 1-2, roversi2017interdomainconformationalflexibility pages 2-2)

Reported structural dimensions from crystals: molecules of approximately 6 × 8 × 12 nm. (roversi2017interdomainconformationalflexibility pages 1-2)

  1. Recent developments (prioritized 2023–2024)

5.1 2023: A “glyco-code” for ER chaperone selection (Guay et al., Molecular Cell; 2023-12; https://doi.org/10.1016/j.molcel.2023.11.006)

Concept: UGGT1-mediated reglucosylation is framed as a programmable “glyco-code” that determines which ER chaperones engage a given glycoprotein and when during maturation. (guay2023erchaperonesuse pages 8-10, guay2023erchaperonesuse pages 1-3)

Quantitative data (notable statistics): In the serpin models alpha-1 antitrypsin (AAT) and antithrombin III (ATIII), wild-type AAT was reported as ~23% glucosylated and wild-type ATIII as ~31% glucosylated, indicating differing baseline engagement by the UGGT/lectin system. (guay2023erchaperonesuse pages 8-10)

UGGT isoform contribution: UGGT1 deletion reduced monoglucosylated AAT by more than half and reduced ATIII glucosylation by ~25%, while UGGT1/2 double deletion abolished glucosylation, establishing UGGT1 as the predominant writer of monoglucosylation for these substrates. (guay2023erchaperonesuse pages 8-10)

Site selectivity: UGGT preferentially modifies particular glycosylation sites (e.g., AAT N247 more than N83; ATIII N192 highest among assayed sites), supporting a positional logic to the glyco-code. (guay2023erchaperonesuse pages 10-11)

5.2 2024: UGGT1 competes with ERAD to delay degradation (Ninagawa et al., eLife; 2024-09; https://doi.org/10.1101/2023.10.18.562958)

Finding: In human cells with genetic disruption of UGGT1/2, UGGT1 was shown to delay degradation of misfolded and unstable glycoproteins (including ATF6α), contradicting earlier assumptions that reglucosylation does not affect degradation rates for some substrates. (ninagawa2024uggt1mediatedreglucosylationof pages 1-5)

Mechanistic framing: The authors propose a “tug-of-war” where UGGT1-driven reglucosylation and refolding compete against EDEM-family mannose trimming that commits substrates to glycoprotein ERAD. (ninagawa2024uggt1mediatedreglucosylationof pages 1-5)

Isoform dependence and abundance estimate: UGGT2 protein levels were much lower than UGGT1, estimated at ~6.9% of UGGT1 in HCT116 cells and ~29.8% in HeLa, consistent with UGGT1 being the dominant determinant of the observed ERAD-delay phenotype. (ninagawa2024uggt1mediatedreglucosylationof pages 5-9)

5.3 2024: Structural and functional dissection of the UGGT1–SEP15/SELENOF complex (Williams et al., PNAS; 2024-08; https://doi.org/10.1073/pnas.2315009121)

Structural modeling: AlphaFold2/AlphaFold-multimer models predict a specific UGGT1/SEP15 complex with interface features (including buried surface area contributions from UGGT1 residues such as F243, F244, L262) and position SEP15’s redox-active selenocysteine proximal to UGGT1’s catalytic region, suggesting a potential redox-adjacent modulatory role. (williams2024insightsintothe pages 4-5, williams2024insightsintothe pages 2-3)

Experimental validation (quantitative): Coimmunoprecipitation showed ~27% of expressed SEP15 co-occurs with UGGT1; interface mutants in UGGT1 markedly reduced binding (to ~3.8% and ~6.5% SEP15 bound, depending on mutant). (williams2024insightsintothe pages 5-6)

Client modulation: In SELENOF/ALG6 double knockout cells, quantitative glycoproteomics found 26 proteins with significantly altered UGGT-mediated glucosylation, with seven proteins showing ≥50% changes in reglucosylation, indicating SEP15 affects a subset of UGGT1’s cellular client landscape rather than globally shifting all UGGT activity. (williams2024insightsintothe pages 5-6)

  1. Current applications and real-world implementations

6.1 Host-factor biology and antiviral concepts

Hepatitis C virus (HCV) entry: UGGT1 was identified as an SR-BI-interacting protein, and UGGT1 silencing reduced SR-BI protein level and reduced HCV entry/infection, supporting UGGT1 as a proviral host factor via its role in ER quality control and folding of the N-glycosylated entry co-receptor SR-BI. (Frontiers in Microbiology; 2019-09; https://doi.org/10.3389/fmicb.2019.02043) (huang2019srbiinteractomeanalysis pages 1-2, huang2019srbiinteractomeanalysis pages 8-11)

Therapeutic angle (expert analysis): A structural/virology-focused dissertation assessing calnexin cycle components discusses UGGT1 inhibition as a candidate host-target antiviral concept and notes that only UDP (product) is a known small-molecule inhibitor in that context, motivating fragment-based discovery; it also reports virus-specific dependence of different viruses on UGGT isoforms (e.g., UGGT1 KO reducing Zika secretion in their assays). (hill2018structuralcharacterisationof pages 32-36, hill2018structuralcharacterisationof pages 212-217)

6.2 Proteostasis engineering / biomanufacturing-relevant implications

UGGT1 as an anti-aggregation/solubilizing factor: In a cell-based primary study, UGGT1 enzymatic activity increased the soluble fraction of misfolded alpha-1 antitrypsin variants (NHK, ATZ) and reduced insoluble aggregation/polymerization signals, consistent with a role in maintaining ER solubility of folding intermediates through monoglucosylation and lectin-chaperone cycling. (Molecular Biology of the Cell; 2013-09; https://doi.org/10.1091/mbc.e13-02-0101) (ferris2013udpglucoseglycoproteinglucosyltransferase(uggt1) pages 2-3, ferris2013udpglucoseglycoproteinglucosyltransferase(uggt1) pages 7-8)

This mechanism implies practical leverage points in recombinant glycoprotein production and in therapeutic protein engineering: modulating UGGT1/lectin-cycle engagement can shift the balance between soluble folding intermediates and aggregated material for difficult-to-fold glycoproteins. (ferris2013udpglucoseglycoproteinglucosyltransferase(uggt1) pages 2-3, suzuki2021foldingandquality pages 9-10)

  1. Expert opinions and authoritative interpretations (with evidence basis)

UGGT1 as “gatekeeper/checkpoint”: Reviews and primary literature consistently characterize UGGT as the folding checkpoint in the ER lectin cycle—its unique role is to selectively reglucosylate non-native glycoproteins to retain them in the ER, preventing premature ER exit. (roversi2017interdomainconformationalflexibility pages 1-2, adams2020quantitativeglycoproteomicsreveals pages 1-4)

Flexibility enables broad surveillance: Structural work interprets interdomain conformational flexibility as a functional requirement for recognizing a wide variety of misfolded glycoprotein conformations and for geometrically reaching glycans positioned variably relative to folding defects. (roversi2017interdomainconformationalflexibility pages 1-2, roversi2017interdomainconformationalflexibility pages 2-2)

UGGT1 vs UGGT2 division of labor: Proteomics-based and functional work supports an isoform specialization in which UGGT1 is the dominant reglucosyltransferase in many cellular contexts and preferentially modifies large, complex (often membrane/plasma-membrane targeted) substrates, while UGGT2 preferentially modifies smaller soluble/lysosomal proteins and may be lower abundance in some cell types. (adams2020quantitativeglycoproteomicsreveals pages 1-4, ninagawa2024uggt1mediatedreglucosylationof pages 5-9)

  1. Key statistics and data points (selected)

Reglucosylation prevalence and isoform dependence in serpins (2023): WT AAT ~23% glucosylated; WT ATIII ~31% glucosylated; UGGT1 deletion reduces AAT monoglucosylation by >50% and reduces ATIII glucosylation by ~25%; UGGT1/2 double deletion abolishes glucosylation. (guay2023erchaperonesuse pages 8-10)

SEP15 modulation of UGGT1 client set (2024): ~27% SEP15 co-occurs with UGGT1; binding reduced to ~3.8% and ~6.5% by UGGT interface mutants; 26 proteins significantly altered in glucosylation in SELENOF−/−/ALG6−/− vs ALG6−/−, with seven proteins changing ≥50%. (williams2024insightsintothe pages 5-6)

UGGT2 relative abundance estimates (2024): ~6.9% (HCT116) and ~29.8% (HeLa) relative to UGGT1 (as reported in the study’s experimental context). (ninagawa2024uggt1mediatedreglucosylationof pages 5-9)

Structural/biophysical metrics: UGGT crystal molecule size ~6 × 8 × 12 nm; cryo-EM reconstruction ~15 Å; ability to target glycans ≥~40 Å from local disorder. (roversi2017interdomainconformationalflexibility pages 1-2, suzuki2021foldingandquality pages 9-10)

  1. Limitations and open questions (evidence-based)

Catalytic parameters (Km/kcat) and detailed acceptor-branch specificity for human UGGT1 are not directly reported in the retrieved excerpts; therefore, this report focuses on validated qualitative/quantitative cellular readouts (monoglucosylation fractions, substrate lists, binding fractions) and structural principles rather than enzyme kinetics. (takeda2016effectsofdomain pages 1-2, guay2023erchaperonesuse pages 8-10)

UGGT1’s precise rules for choosing which glycan(s) on a multi-glycosylated substrate to reglucosylate are being clarified by recent site-selective glycoproteomics (“glyco-code”), but the generality of these rules across diverse endogenous clients remains an active research area. (guay2023erchaperonesuse pages 8-10, guay2023erchaperonesuse pages 10-11)

References (URLs and publication dates)

Key 2023–2024 primary sources emphasized in this report:

• Guay KP et al. “ER chaperones use a protein folding and quality control glyco-code.” Molecular Cell. Published online 2023-12 (issue Dec 2023). https://doi.org/10.1016/j.molcel.2023.11.006 (guay2023erchaperonesuse pages 8-10, guay2023erchaperonesuse pages 10-11)

• Ninagawa S et al. “UGGT1-mediated reglucosylation of N-glycan competes with ER-associated degradation of unstable and misfolded glycoproteins.” eLife. 2024-09. https://doi.org/10.1101/2023.10.18.562958 (ninagawa2024uggt1mediatedreglucosylationof pages 1-5, ninagawa2024uggt1mediatedreglucosylationof pages 5-9)

• Williams RV et al. “Insights into the interaction between UGGT, the gatekeeper of folding in the ER, and its partner, the selenoprotein SEP15.” PNAS. 2024-08. https://doi.org/10.1073/pnas.2315009121 (williams2024insightsintothe pages 5-6, williams2024insightsintothe pages 4-5, williams2024insightsintothe pages 2-3)

Other foundational/interpretive sources used:

• Kozlov G, Gehring K. “Calnexin cycle – structural features of the ER chaperone system.” FEBS Journal. 2020-04. https://doi.org/10.1111/febs.15330 (kozlov2020calnexincycle– media d42ce2c5)

• Adams BM et al. “Quantitative glycoproteomics reveals cellular substrate selectivity of the ER protein quality control sensors UGGT1 and UGGT2.” eLife. 2020-12. https://doi.org/10.7554/eLife.63997 (adams2020quantitativeglycoproteomicsreveals pages 1-4)

• Roversi P et al. “Interdomain conformational flexibility underpins the activity of UGGT, the eukaryotic glycoprotein secretion checkpoint.” PNAS. 2017-07. https://doi.org/10.1073/pnas.1703682114 (roversi2017interdomainconformationalflexibility pages 1-2, roversi2017interdomainconformationalflexibility pages 2-2)

• Takeda Y et al. “Effects of domain composition on catalytic activity of human UDP-glucose:glycoprotein glucosyltransferases.” Glycobiology. 2016-07. https://doi.org/10.1093/glycob/cww069 (takeda2016effectsofdomain pages 1-2)

• Suzuki T, Fujihira H. “Folding and Quality Control of Glycoproteins.” Comprehensive Glycoscience (book chapter). 2021-12. https://doi.org/10.1016/B978-0-12-409547-2.14947-9 (suzuki2021foldingandquality pages 9-10)

• Ferris SP et al. “UDP-glucose:glycoprotein glucosyltransferase (UGGT1) promotes substrate solubility in the endoplasmic reticulum.” Molecular Biology of the Cell. 2013-09. https://doi.org/10.1091/mbc.e13-02-0101 (ferris2013udpglucoseglycoproteinglucosyltransferase(uggt1) pages 2-3)

• Huang J et al. “SR-BI Interactome Analysis Reveals a Proviral Role for UGGT1 in Hepatitis C Virus Entry.” Frontiers in Microbiology. 2019-09. https://doi.org/10.3389/fmicb.2019.02043 (huang2019srbiinteractomeanalysis pages 1-2, huang2019srbiinteractomeanalysis pages 8-11)

• Hill JC. “Structural characterisation of calnexin cycle components and assessment as antiviral targets.” Dissertation. 2018-01. https://doi.org/10.5287/ora-o8dxekdy4 (hill2018structuralcharacterisationof pages 32-36, hill2018structuralcharacterisationof pages 212-217)

References

  1. (suzuki2021foldingandquality pages 9-10): Tadashi Suzuki and Haruhiko Fujihira. Folding and quality control of glycoproteins. Comprehensive Glycoscience, pages 1-28, Dec 2021. URL: https://doi.org/10.1016/b978-0-12-409547-2.14947-9, doi:10.1016/b978-0-12-409547-2.14947-9. This article has 11 citations.

  2. (roversi2017interdomainconformationalflexibility pages 1-2): Pietro Roversi, Lucia Marti, Alessandro T. Caputo, Dominic S. Alonzi, Johan C. Hill, Kyle C. Dent, Abhinav Kumar, Mikail D. Levasseur, Andrea Lia, Thomas Waksman, Souradeep Basu, Yentli Soto Albrecht, Kristin Qian, James Patrick McIvor, Colette B. Lipp, Dritan Siliqi, Snežana Vasiljević, Shabaz Mohammed, Petra Lukacik, Martin A. Walsh, Angelo Santino, and Nicole Zitzmann. Interdomain conformational flexibility underpins the activity of uggt, the eukaryotic glycoprotein secretion checkpoint. Proceedings of the National Academy of Sciences, 114:8544-8549, Jul 2017. URL: https://doi.org/10.1073/pnas.1703682114, doi:10.1073/pnas.1703682114. This article has 66 citations and is from a highest quality peer-reviewed journal.

  3. (adams2020quantitativeglycoproteomicsreveals pages 1-4): Benjamin M Adams, Nathan P Canniff, Kevin P Guay, Ida Signe Bohse Larsen, and Daniel N Hebert. Quantitative glycoproteomics reveals cellular substrate selectivity of the er protein quality control sensors uggt1 and uggt2. eLife, Dec 2020. URL: https://doi.org/10.7554/elife.63997, doi:10.7554/elife.63997. This article has 68 citations and is from a domain leading peer-reviewed journal.

  4. (guay2023erchaperonesuse pages 8-10): Kevin P. Guay, Haiping Ke, Nathan P. Canniff, Gracie T. George, Stephen J. Eyles, Malaiyalam Mariappan, Joseph N. Contessa, Anne Gershenson, Lila M. Gierasch, and Daniel N. Hebert. Er chaperones use a protein folding and quality control glyco-code. Molecular Cell, 83:4524-4537.e5, Dec 2023. URL: https://doi.org/10.1016/j.molcel.2023.11.006, doi:10.1016/j.molcel.2023.11.006. This article has 26 citations and is from a highest quality peer-reviewed journal.

  5. (ninagawa2024uggt1mediatedreglucosylationof pages 1-5): Satoshi Ninagawa, Masaki Matsuo, Deng Ying, Shuichiro Oshita, Shinya Aso, Kazutoshi Matsushita, Mai Taniguchi, Akane Fueki, Moe Yamashiro, Kaoru Sugasawa, Shunsuke Saito, Koshi Imami, Yasuhiko Kizuka, Tetsushi Sakuma, Takashi Yamamoto, Hirokazu Yagi, Koichi Kato, and Kazutoshi Mori. Uggt1-mediated reglucosylation of n-glycan competes with er-associated degradation of unstable and misfolded glycoproteins. eLife, Sep 2024. URL: https://doi.org/10.1101/2023.10.18.562958, doi:10.1101/2023.10.18.562958. This article has 6 citations and is from a domain leading peer-reviewed journal.

  6. (williams2024insightsintothe pages 5-6): Robert V. Williams, Kevin P. Guay, Owen A. Hurlbut Lesk, Eugenia M. Clerico, Daniel N. Hebert, and Lila M. Gierasch. Insights into the interaction between uggt, the gatekeeper of folding in the er, and its partner, the selenoprotein sep15. Proceedings of the National Academy of Sciences of the United States of America, Aug 2024. URL: https://doi.org/10.1073/pnas.2315009121, doi:10.1073/pnas.2315009121. This article has 10 citations and is from a highest quality peer-reviewed journal.

  7. (takeda2016effectsofdomain pages 1-2): Yoichi Takeda, Akira Seko, Kohki Fujikawa, Masayuki Izumi, Yasuhiro Kajihara, and Yukishige Ito. Effects of domain composition on catalytic activity of human udp-glucose:glycoprotein glucosyltransferases. Glycobiology, 26:999-1006, Jul 2016. URL: https://doi.org/10.1093/glycob/cww069, doi:10.1093/glycob/cww069. This article has 22 citations and is from a peer-reviewed journal.

  8. (kozlov2020calnexincycle– media d42ce2c5): Guennadi Kozlov and Kalle Gehring. Calnexin cycle – structural features of the er chaperone system. The FEBS Journal, 287:4322-4340, Apr 2020. URL: https://doi.org/10.1111/febs.15330, doi:10.1111/febs.15330. This article has 216 citations.

  9. (roversi2017interdomainconformationalflexibility pages 2-2): Pietro Roversi, Lucia Marti, Alessandro T. Caputo, Dominic S. Alonzi, Johan C. Hill, Kyle C. Dent, Abhinav Kumar, Mikail D. Levasseur, Andrea Lia, Thomas Waksman, Souradeep Basu, Yentli Soto Albrecht, Kristin Qian, James Patrick McIvor, Colette B. Lipp, Dritan Siliqi, Snežana Vasiljević, Shabaz Mohammed, Petra Lukacik, Martin A. Walsh, Angelo Santino, and Nicole Zitzmann. Interdomain conformational flexibility underpins the activity of uggt, the eukaryotic glycoprotein secretion checkpoint. Proceedings of the National Academy of Sciences, 114:8544-8549, Jul 2017. URL: https://doi.org/10.1073/pnas.1703682114, doi:10.1073/pnas.1703682114. This article has 66 citations and is from a highest quality peer-reviewed journal.

  10. (guay2023erchaperonesuse pages 1-3): Kevin P. Guay, Haiping Ke, Nathan P. Canniff, Gracie T. George, Stephen J. Eyles, Malaiyalam Mariappan, Joseph N. Contessa, Anne Gershenson, Lila M. Gierasch, and Daniel N. Hebert. Er chaperones use a protein folding and quality control glyco-code. Molecular Cell, 83:4524-4537.e5, Dec 2023. URL: https://doi.org/10.1016/j.molcel.2023.11.006, doi:10.1016/j.molcel.2023.11.006. This article has 26 citations and is from a highest quality peer-reviewed journal.

  11. (guay2023erchaperonesuse pages 10-11): Kevin P. Guay, Haiping Ke, Nathan P. Canniff, Gracie T. George, Stephen J. Eyles, Malaiyalam Mariappan, Joseph N. Contessa, Anne Gershenson, Lila M. Gierasch, and Daniel N. Hebert. Er chaperones use a protein folding and quality control glyco-code. Molecular Cell, 83:4524-4537.e5, Dec 2023. URL: https://doi.org/10.1016/j.molcel.2023.11.006, doi:10.1016/j.molcel.2023.11.006. This article has 26 citations and is from a highest quality peer-reviewed journal.

  12. (ninagawa2024uggt1mediatedreglucosylationof pages 5-9): Satoshi Ninagawa, Masaki Matsuo, Deng Ying, Shuichiro Oshita, Shinya Aso, Kazutoshi Matsushita, Mai Taniguchi, Akane Fueki, Moe Yamashiro, Kaoru Sugasawa, Shunsuke Saito, Koshi Imami, Yasuhiko Kizuka, Tetsushi Sakuma, Takashi Yamamoto, Hirokazu Yagi, Koichi Kato, and Kazutoshi Mori. Uggt1-mediated reglucosylation of n-glycan competes with er-associated degradation of unstable and misfolded glycoproteins. eLife, Sep 2024. URL: https://doi.org/10.1101/2023.10.18.562958, doi:10.1101/2023.10.18.562958. This article has 6 citations and is from a domain leading peer-reviewed journal.

  13. (williams2024insightsintothe pages 4-5): Robert V. Williams, Kevin P. Guay, Owen A. Hurlbut Lesk, Eugenia M. Clerico, Daniel N. Hebert, and Lila M. Gierasch. Insights into the interaction between uggt, the gatekeeper of folding in the er, and its partner, the selenoprotein sep15. Proceedings of the National Academy of Sciences of the United States of America, Aug 2024. URL: https://doi.org/10.1073/pnas.2315009121, doi:10.1073/pnas.2315009121. This article has 10 citations and is from a highest quality peer-reviewed journal.

  14. (williams2024insightsintothe pages 2-3): Robert V. Williams, Kevin P. Guay, Owen A. Hurlbut Lesk, Eugenia M. Clerico, Daniel N. Hebert, and Lila M. Gierasch. Insights into the interaction between uggt, the gatekeeper of folding in the er, and its partner, the selenoprotein sep15. Proceedings of the National Academy of Sciences of the United States of America, Aug 2024. URL: https://doi.org/10.1073/pnas.2315009121, doi:10.1073/pnas.2315009121. This article has 10 citations and is from a highest quality peer-reviewed journal.

  15. (huang2019srbiinteractomeanalysis pages 1-2): Jiazhao Huang, Han Yin, Peiqi Yin, Xia Jian, Siqi Song, Junwen Luan, and Leiliang Zhang. Sr-bi interactome analysis reveals a proviral role for uggt1 in hepatitis c virus entry. Frontiers in Microbiology, Sep 2019. URL: https://doi.org/10.3389/fmicb.2019.02043, doi:10.3389/fmicb.2019.02043. This article has 12 citations and is from a peer-reviewed journal.

  16. (huang2019srbiinteractomeanalysis pages 8-11): Jiazhao Huang, Han Yin, Peiqi Yin, Xia Jian, Siqi Song, Junwen Luan, and Leiliang Zhang. Sr-bi interactome analysis reveals a proviral role for uggt1 in hepatitis c virus entry. Frontiers in Microbiology, Sep 2019. URL: https://doi.org/10.3389/fmicb.2019.02043, doi:10.3389/fmicb.2019.02043. This article has 12 citations and is from a peer-reviewed journal.

  17. (hill2018structuralcharacterisationof pages 32-36): Johan C Hill. Structural characterisation of calnexin cycle components and assessment as antiviral targets. Dissertation, Jan 2018. URL: https://doi.org/10.5287/ora-o8dxekdy4, doi:10.5287/ora-o8dxekdy4. This article has 3 citations.

  18. (hill2018structuralcharacterisationof pages 212-217): Johan C Hill. Structural characterisation of calnexin cycle components and assessment as antiviral targets. Dissertation, Jan 2018. URL: https://doi.org/10.5287/ora-o8dxekdy4, doi:10.5287/ora-o8dxekdy4. This article has 3 citations.

  19. (ferris2013udpglucoseglycoproteinglucosyltransferase(uggt1) pages 2-3): Sean P. Ferris, Nikita S. Jaber, Maurizio Molinari, Peter Arvan, and Randal J. Kaufman. Udp-glucose:glycoprotein glucosyltransferase (uggt1) promotes substrate solubility in the endoplasmic reticulum. Molecular Biology of the Cell, 24:2597-2608, Sep 2013. URL: https://doi.org/10.1091/mbc.e13-02-0101, doi:10.1091/mbc.e13-02-0101. This article has 69 citations and is from a domain leading peer-reviewed journal.

  20. (ferris2013udpglucoseglycoproteinglucosyltransferase(uggt1) pages 7-8): Sean P. Ferris, Nikita S. Jaber, Maurizio Molinari, Peter Arvan, and Randal J. Kaufman. Udp-glucose:glycoprotein glucosyltransferase (uggt1) promotes substrate solubility in the endoplasmic reticulum. Molecular Biology of the Cell, 24:2597-2608, Sep 2013. URL: https://doi.org/10.1091/mbc.e13-02-0101, doi:10.1091/mbc.e13-02-0101. This article has 69 citations and is from a domain leading peer-reviewed journal.

Citations

  1. suzuki2021foldingandquality pages 9-10
  2. roversi2017interdomainconformationalflexibility pages 1-2
  3. guay2023erchaperonesuse pages 8-10
  4. guay2023erchaperonesuse pages 10-11
  5. williams2024insightsintothe pages 5-6
  6. adams2020quantitativeglycoproteomicsreveals pages 1-4
  7. takeda2016effectsofdomain pages 1-2
  8. roversi2017interdomainconformationalflexibility pages 2-2
  9. guay2023erchaperonesuse pages 1-3
  10. williams2024insightsintothe pages 4-5
  11. williams2024insightsintothe pages 2-3
  12. huang2019srbiinteractomeanalysis pages 1-2
  13. huang2019srbiinteractomeanalysis pages 8-11
  14. hill2018structuralcharacterisationof pages 32-36
  15. hill2018structuralcharacterisationof pages 212-217
  16. https://doi.org/10.1016/j.molcel.2023.11.006
  17. https://doi.org/10.1101/2023.10.18.562958
  18. https://doi.org/10.1073/pnas.2315009121
  19. https://doi.org/10.3389/fmicb.2019.02043
  20. https://doi.org/10.1091/mbc.e13-02-0101
  21. https://doi.org/10.1111/febs.15330
  22. https://doi.org/10.7554/eLife.63997
  23. https://doi.org/10.1073/pnas.1703682114
  24. https://doi.org/10.1093/glycob/cww069
  25. https://doi.org/10.1016/B978-0-12-409547-2.14947-9
  26. https://doi.org/10.5287/ora-o8dxekdy4
  27. https://doi.org/10.1016/b978-0-12-409547-2.14947-9,
  28. https://doi.org/10.1073/pnas.1703682114,
  29. https://doi.org/10.7554/elife.63997,
  30. https://doi.org/10.1016/j.molcel.2023.11.006,
  31. https://doi.org/10.1101/2023.10.18.562958,
  32. https://doi.org/10.1073/pnas.2315009121,
  33. https://doi.org/10.1093/glycob/cww069,
  34. https://doi.org/10.1111/febs.15330,
  35. https://doi.org/10.3389/fmicb.2019.02043,
  36. https://doi.org/10.5287/ora-o8dxekdy4,
  37. https://doi.org/10.1091/mbc.e13-02-0101,

📄 View Raw YAML

id: Q9NYU2
gene_symbol: UGGT1
product_type: PROTEIN
status: IN_PROGRESS
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  UDP-glucose:glycoprotein glucosyltransferase 1 (UGGT1) is a large (~173 kDa)
  soluble ER-resident enzyme that serves as the central quality control sensor and
  folding checkpoint in the calnexin/calreticulin cycle. UGGT1 recognizes
  glycoproteins with minor folding defects (preferentially molten-globule-like
  intermediates, not fully folded or completely unfolded proteins) and
  reglucosylates their N-glycans, thereby tagging them for re-engagement with the
  calnexin/calreticulin chaperone system. Its core molecular function is
  UDP-glucose:glycoprotein glucosyltransferase activity (EC 2.4.1.-), transferring
  glucose from UDP-glucose to deglucosylated high-mannose N-glycans on misfolded
  substrates. Structurally, UGGT1 has a seven-domain architecture: four N-terminal
  thioredoxin-like domains (TRXL1-TRXL4) arranged in an arc that mediate substrate
  recognition, two beta-sandwich domains (betaS1, betaS2), and the C-terminal GT24
  catalytic domain (~20% of the protein) (DOI:10.1073/pnas.1703682114). Substantial
  interdomain conformational flexibility enables UGGT1 to accommodate diverse client
  shapes and to glucosylate glycans at least ~40 angstroms from localized disordered
  regions. UGGT1 writes a site-selective "glyco-code" that determines which ER
  chaperones engage substrates and when during maturation
  (DOI:10.1016/j.molcel.2023.11.006). UGGT1-mediated reglucosylation competes with
  EDEM-family mannose trimming in a "tug-of-war" that determines whether substrates
  are retained for refolding or committed to ERAD
  (DOI:10.1101/2023.10.18.562958). UGGT1 activity is modulated by the partner
  selenoprotein SELENOF/SEP15 (DOI:10.1073/pnas.2315009121). UGGT1 is the dominant
  mammalian reglucosyltransferase (UGGT2 is ~7-30% of UGGT1 abundance in tested
  cell lines). Described as a "gatekeeper for quality control" that prevents
  transport of improperly folded glycoproteins out of the ER (PMID:10694380).
alternative_products:
- name: '1'
  id: Q9NYU2-1
- name: '2'
  id: Q9NYU2-2
  sequence_note: VSP_036508
existing_annotations:
- term:
    id: GO:0003980
    label: UDP-glucose:glycoprotein glucosyltransferase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IBA annotation for the core enzymatic function of UGGT1. This is the defining
      molecular function of UGGT1: it transfers glucose from UDP-glucose to
      Man9GlcNAc2 N-glycans on misfolded glycoproteins. This activity has been
      experimentally demonstrated in PMID:10694380 (27-fold increase in glucose
      transfer from UDP-glucose to denatured substrates in HUGT1-transfected cells)
      and confirmed by reglucosylation assays in PMID:40267907. The IBA annotation
      is phylogenetically well-supported and represents the core function.
    action: ACCEPT
    reason: >-
      This is the core molecular function of UGGT1, well-established experimentally
      (PMID:10694380, PMID:40267907) and phylogenetically (IBA). UGGT1 is a
      glycosyltransferase family 24 member (CAZy GT24) that catalyzes the
      reglucosylation of N-glycans on misfolded glycoproteins as part of the ER
      quality control cycle.
    supported_by:
      - reference_id: PMID:10694380
        supporting_text: >-
          Extracts from HUGT1-transfected cells displayed a 27-fold increase in the
          transfer of [(14)C]glucose from UDP-[(14)C]glucose to denatured substrates.
      - reference_id: PMID:40267907
        supporting_text: >-
          UGGT1 encodes UDP-glucose:glycoprotein glucosyltransferase 1, an enzyme
          critical for maintaining quality control of N-linked glycosylation.
- term:
    id: GO:0005783
    label: endoplasmic reticulum
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IBA annotation for ER localization. UGGT1 contains an N-terminal signal
      peptide and a C-terminal REEL ER-retrieval motif (UniProt). Arnold et al.
      (PMID:10694380) confirmed ER localization experimentally. This IBA is
      consistent with the more specific IEA annotation to ER lumen (GO:0005788).
      While GO:0005788 (ER lumen) is more precise, GO:0005783 (endoplasmic
      reticulum) is acceptable as a broader parent term and is correctly inferred
      phylogenetically.
    action: ACCEPT
    reason: >-
      UGGT1 is an established ER-resident protein. It contains the REEL ER
      retrieval signal (UniProt), and experimental localization was confirmed in
      PMID:10694380. The IBA annotation at this level is appropriate and consistent
      with more specific ER lumen and ERGIC annotations.
    supported_by:
      - reference_id: PMID:10694380
        supporting_text: >-
          HUGT1 encodes a 1555 amino acid polypeptide that, upon cleavage of an
          N-terminal signal peptide, is predicted to produce a soluble 173 kDa
          protein with the ER retrieval signal REEL.
- term:
    id: GO:0051082
    label: unfolded protein binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      UGGT1 does interact with unfolded/misfolded glycoproteins, but this interaction
      represents substrate recognition for its glucosyltransferase enzymatic activity
      (GO:0003980), not an independent binding function. The N-terminal non-catalytic
      domain recognizes glycoproteins with minor folding defects (UniProt FUNCTION
      annotation, PMID:10694380), and this recognition is prerequisite to the catalytic
      reglucosylation step. This is analogous to how a kinase recognizes its protein
      substrates -- we would not annotate a kinase with "substrate protein binding"
      simply because it must bind substrates to phosphorylate them. The term GO:0051082
      is also being obsoleted (go-ontology#30962). The IBA was propagated from
      experimental annotations on UGGT1 orthologs, but the underlying experimental
      evidence reflects the same substrate-recognition mechanism.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      UGGT1 binding to unfolded proteins is incidental to its core enzymatic function
      as a UDP-glucose:glycoprotein glucosyltransferase. The protein recognizes
      misfolded glycoproteins as substrates for reglucosylation, not as an independent
      binding/chaperone function. As described in PMID:10694380, UGGT1 "operates as a
      gatekeeper for quality control by preventing transport of improperly folded
      glycoproteins out of the ER" through its glucosyltransferase activity -- the
      substrate recognition is integral to and subsumed by the enzymatic activity
      annotation GO:0003980. Additionally, GO:0051082 is being obsoleted per
      go-ontology#30962.
    supported_by:
      - reference_id: PMID:10694380
        supporting_text: >-
          UDP-glucose:glycoprotein glucosyltransferase (UGT) is a soluble protein of
          the endoplasmic reticulum (ER) that operates as a gatekeeper for quality
          control by preventing transport of improperly folded glycoproteins out of the
          ER.
- term:
    id: GO:0044322
    label: endoplasmic reticulum quality control compartment
  evidence_type: IEA
  original_reference_id: GO_REF:0000108
  review:
    summary: >-
      IEA annotation placing UGGT1 in the ER quality control compartment (ERQC).
      The ERQC is defined as "a subcompartment of the endoplasmic reticulum in which
      proteins with improper or incorrect folding accumulate." UGGT1 is a central
      enzyme in this compartment, acting as the folding sensor that reglucosylates
      misfolded glycoproteins for re-engagement with calnexin/calreticulin
      (PMID:10694380, PMID:40267907). The Reactome pathway R-HSA-901032 explicitly
      places UGGT1 in the ERQC. This is an appropriate and informative localization
      annotation.
    action: ACCEPT
    reason: >-
      UGGT1 is a core component of the ERQC, functioning as the folding sensor that
      determines whether glycoproteins are retained for further folding attempts.
      Reactome R-HSA-901032 explicitly models UGGT1 in this compartment. The IEA
      annotation is well-supported by the known biology of UGGT1.
    supported_by:
      - reference_id: PMID:40267907
        supporting_text: >-
          UGGT1 identifies and reglucosylates misfolded proteins, resulting in ER
          retention for re-binding to CNX/CRT to enable correct folding.
- term:
    id: GO:0097359
    label: UDP-glucosylation
  evidence_type: IEA
  original_reference_id: GO_REF:0000108
  review:
    summary: >-
      IEA annotation for the biological process of UDP-glucosylation. GO:0097359 is
      defined as "the covalent attachment of a UDP-glucose residue to a substrate
      molecule." This accurately describes the process UGGT1 catalyzes: transferring
      glucose from UDP-glucose to Man9GlcNAc2 N-glycans on misfolded glycoproteins.
      The annotation is logically inferred from the MF annotation GO:0003980 and is
      correct.
    action: ACCEPT
    reason: >-
      UDP-glucosylation is the direct process outcome of UGGT1's enzymatic activity.
      The annotation is correctly inferred from the molecular function GO:0003980
      (UDP-glucose:glycoprotein glucosyltransferase activity). It accurately captures
      what UGGT1 does at the process level.
    supported_by:
      - reference_id: PMID:10694380
        supporting_text: >-
          Extracts from HUGT1-transfected cells displayed a 27-fold increase in the
          transfer of [(14)C]glucose from UDP-[(14)C]glucose to denatured substrates.
- term:
    id: GO:0003980
    label: UDP-glucose:glycoprotein glucosyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      IEA annotation for UGGT1 glucosyltransferase activity from combined automated
      methods. This is a redundant annotation for the same GO term as the IBA and IDA
      annotations, but that is acceptable. The annotation correctly identifies UGGT1's
      core enzymatic function.
    action: ACCEPT
    reason: >-
      Correct assignment of the core molecular function. While redundant with the IBA
      and IDA annotations to GO:0003980, duplicate annotations with different evidence
      codes are acceptable.
    supported_by:
      - reference_id: PMID:10694380
        supporting_text: >-
          Extracts from HUGT1-transfected cells displayed a 27-fold increase in the
          transfer of [(14)C]glucose from UDP-[(14)C]glucose to denatured substrates.
- term:
    id: GO:0005788
    label: endoplasmic reticulum lumen
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: >-
      IEA annotation for ER lumen localization based on UniProt subcellular location
      mapping. UGGT1 is a soluble protein that resides in the ER lumen; it contains
      an N-terminal signal peptide (cleaved) and the C-terminal REEL ER retrieval
      signal (UniProt). Arnold et al. (PMID:10694380) confirmed ER localization.
      UniProt explicitly annotates SUBCELLULAR LOCATION as "Endoplasmic reticulum
      lumen." This is more specific than GO:0005783 and accurately captures where
      UGGT1 resides.
    action: ACCEPT
    reason: >-
      UGGT1 is a soluble, luminal ER protein. UniProt annotation with experimental
      evidence (PMID:10694380) and PROSITE ER-targeting motif (PRU10138) confirm
      ER lumen localization. This is the most appropriate CC annotation for UGGT1.
    supported_by:
      - reference_id: PMID:10694380
        supporting_text: >-
          HUGT1 encodes a 1555 amino acid polypeptide that, upon cleavage of an
          N-terminal signal peptide, is predicted to produce a soluble 173 kDa
          protein with the ER retrieval signal REEL.
- term:
    id: GO:0005793
    label: endoplasmic reticulum-Golgi intermediate compartment
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: >-
      IEA annotation for ERGIC localization based on UniProt subcellular location
      mapping. UniProt annotates UGGT1 SUBCELLULAR LOCATION as including
      "Endoplasmic reticulum-Golgi intermediate compartment" based on PROSITE
      and experimental evidence (PMID:10694380). UGGT1 cycles through the ERGIC
      as part of its ER retrieval mechanism, though its primary site of action
      is the ER lumen/ERQC. This is consistent with its ER retrieval signal
      (REEL) which would enable cycling through the ERGIC.
    action: ACCEPT
    reason: >-
      UniProt annotates UGGT1 to ERGIC, and an ISS annotation also supports this
      localization. UGGT1 contains the REEL retrieval signal which mediates cycling
      through the secretory pathway, consistent with ERGIC presence. While the
      primary functional site is the ER lumen, ERGIC presence is expected for
      ER-retrieved proteins.
    supported_by:
      - reference_id: PMID:10694380
        supporting_text: >-
          HUGT1 encodes a 1555 amino acid polypeptide that, upon cleavage of an
          N-terminal signal peptide, is predicted to produce a soluble 173 kDa
          protein with the ER retrieval signal REEL.
- term:
    id: GO:0009101
    label: glycoprotein biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      IEA annotation from InterPro mapping. GO:0009101 (glycoprotein biosynthetic
      process) is defined as "the chemical reactions and pathways resulting in the
      formation of glycoproteins." While UGGT1 does modify glycoproteins by adding
      glucose to their N-glycans, its role is in quality control and reglucosylation
      of already-formed glycoproteins, not in de novo glycoprotein biosynthesis.
      UGGT1 acts after the initial glycosylation and trimming steps, adding glucose
      back to N-glycans on misfolded proteins to retain them in the ER for refolding.
      This is better described as protein N-linked glycosylation (GO:0006487) or
      more specifically the ERQC pathway, rather than glycoprotein biosynthesis
      per se.
    action: MODIFY
    reason: >-
      UGGT1 does not participate in de novo glycoprotein biosynthesis. It acts
      downstream in the quality control cycle, reglucosylating N-glycans on
      misfolded glycoproteins that have already been synthesized and initially
      glycosylated. The IBA annotation to GO:0018279 (protein N-linked glycosylation
      via asparagine) is a more appropriate process term, and GO:0006487 (protein
      N-linked glycosylation) would also be suitable. GO:0009101 is misleading
      because UGGT1 does not contribute to glycoprotein biosynthesis in the usual
      sense.
    proposed_replacement_terms:
      - id: GO:0006487
        label: protein N-linked glycosylation
- term:
    id: GO:0016740
    label: transferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >-
      IEA annotation from UniProt keyword mapping for the broad parent term
      "transferase activity." UGGT1 is indeed a transferase (it transfers glucose
      from UDP-glucose to glycoprotein substrates). However, the more specific term
      GO:0003980 (UDP-glucose:glycoprotein glucosyltransferase activity) is already
      annotated via IBA, IDA, and other IEA sources. GO:0016740 is a very broad
      ancestral term that adds no information beyond what GO:0003980 provides.
    action: ACCEPT
    reason: >-
      While extremely broad, this IEA annotation is not incorrect. UGGT1 is a
      transferase. The more specific child term GO:0003980 is already captured by
      IBA and IDA annotations. It is acceptable for IEA annotations to be broader
      than what is determined by IBA or literature.
- term:
    id: GO:0016757
    label: glycosyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >-
      IEA annotation from UniProt keyword mapping for "glycosyltransferase activity."
      UGGT1 is a member of glycosyltransferase family 24 (CAZy GT24) and is
      classified as such in UniProt. This is a parent term of GO:0003980. While
      less specific than GO:0003980, it is correct and acceptable as an IEA
      annotation.
    action: ACCEPT
    reason: >-
      Correct parent term annotation. UGGT1 belongs to CAZy GT24 and is a
      glycosyltransferase by classification (UniProt KW-0328). The more specific
      GO:0003980 is already annotated. Broader IEA annotations are acceptable.
- term:
    id: GO:1904380
    label: endoplasmic reticulum mannose trimming
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      IEA annotation from ARBA machine learning. GO:1904380 is defined as "any
      protein alpha-1,2-demannosylation that takes place in the endoplasmic
      reticulum quality control compartment (ERQC)." UGGT1 is NOT a mannosidase
      and does NOT trim mannose residues. UGGT1 is a glucosyltransferase that adds
      glucose to N-glycans. Mannose trimming in the ERQC is carried out by ER
      mannosidase I (MAN1B1) and EDEM family members (PMID:40267907). This
      annotation is incorrect and was likely mis-assigned by the ARBA model.
    action: REMOVE
    reason: >-
      UGGT1 does not perform mannose trimming. It is a glucosyltransferase that
      adds glucose to Man9GlcNAc2 N-glycans on misfolded glycoproteins. Mannose
      trimming is carried out by distinct enzymes (ERManI/MAN1B1, EDEM1/2/3) that
      act in the ERQC pathway. While UGGT1 operates in the same pathway as the
      mannose trimming enzymes, it performs an entirely different enzymatic reaction
      (glucosylation, not demannosylation). This is an incorrect ARBA prediction.
    supported_by:
      - reference_id: PMID:40267907
        supporting_text: >-
          A molecular marking system involving multiple ER-resident exo-mannosidases,
          including ER mannosidase I (ERManI) and EDEM family members, operates in
          tandem with this cyclical process by progressively trimming mannose residues
          from glycoproteins.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:17353931
  review:
    summary: >-
      IPI annotation for "protein binding" from a large-scale IP-MS study
      (PMID:17353931, Ewing et al. 2007). This study mapped protein-protein
      interactions for 338 bait proteins using immunoprecipitation followed by
      mass spectrometry. UGGT1 was identified as a prey in this screen, but the
      study does not provide specific information about the biological significance
      of the interaction. The term "protein binding" (GO:0005515) is uninformative
      and does not tell us anything about UGGT1's actual function.
    action: REMOVE
    reason: >-
      Per curation guidelines, "protein binding" (GO:0005515) should be avoided as
      it provides no information about the actual molecular function. This annotation
      comes from a large-scale proteomics screen (PMID:17353931) that does not
      provide insight into the specific nature of the interaction. UGGT1 is known to
      interact with SELENOF (PMID:24415556) and METTL23 (PMID:23349634), but these
      are better captured by specific interaction annotations rather than the
      uninformative "protein binding" term.
- term:
    id: GO:0003980
    label: UDP-glucose:glycoprotein glucosyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:40267907
  review:
    summary: >-
      IDA annotation for UGGT1 glucosyltransferase activity from Dardas et al. 2025
      (PMID:40267907). This study identified bi-allelic UGGT1 variants causing a
      congenital disorder of glycosylation (UGGT1-CDG). The authors performed both
      cellular reglucosylation assays and in vitro catalytic activity assays using
      HPLC-based quantification of glucose transfer. Pathogenic UGGT1 variants were
      shown to impair glucosylation and catalytic activity, providing direct
      evidence for UGGT1 as a UDP-glucose:glycoprotein glucosyltransferase.
    action: ACCEPT
    reason: >-
      Strong experimental evidence from direct enzymatic assays. Dardas et al.
      (PMID:40267907) used both cellular reglucosylation assays (calreticulin
      pull-down) and in vitro catalytic activity assays (HPLC-based glucose transfer
      quantification) to demonstrate UGGT1 glucosyltransferase activity. Pathogenic
      variants showed impaired activity, confirming the enzymatic function.
    supported_by:
      - reference_id: PMID:40267907
        supporting_text: >-
          Molecular studies showed that pathogenic UGGT1 variants impair UGGT1
          glucosylation and catalytic activity, disrupt mRNA splicing, or inhibit
          endoplasmic reticulum (ER) retention.
- term:
    id: GO:1904380
    label: endoplasmic reticulum mannose trimming
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-901032
  review:
    summary: >-
      TAS annotation from Reactome pathway R-HSA-901032 (ER Quality Control
      Compartment). UGGT1 is correctly placed in the ERQC pathway by Reactome,
      but GO:1904380 (ER mannose trimming) specifically describes
      alpha-1,2-demannosylation. UGGT1 does not trim mannose; it adds glucose.
      UGGT1 operates in the same quality control pathway as the mannose-trimming
      enzymes but performs a distinct reaction (reglucosylation). This annotation
      is incorrect -- UGGT1 was likely erroneously associated with this process
      term because it is part of the broader ERQC pathway that includes mannose
      trimming steps.
    action: REMOVE
    reason: >-
      UGGT1 does not perform mannose trimming. GO:1904380 is defined as "any
      protein alpha-1,2-demannosylation that takes place in the ERQC." UGGT1 is
      a glucosyltransferase, not a mannosidase. While UGGT1 participates in the
      ERQC pathway alongside mannose-trimming enzymes, it catalyzes the opposite
      modification: adding glucose rather than removing mannose. This annotation
      appears to be a mis-mapping from the Reactome ERQC pathway.
    supported_by:
      - reference_id: PMID:40267907
        supporting_text: >-
          A molecular marking system involving multiple ER-resident exo-mannosidases,
          including ER mannosidase I (ERManI) and EDEM family members, operates in
          tandem with this cyclical process by progressively trimming mannose residues
          from glycoproteins. This stepwise de-mannosylation eventually reduces the
          affinity of UGGT1 for its substrate, preventing further reglucosylation
          and facilitating the extraction of misfolded proteins from the CNX cycle
- term:
    id: GO:0003980
    label: UDP-glucose:glycoprotein glucosyltransferase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-548884
  review:
    summary: >-
      TAS annotation from Reactome reaction R-HSA-548884 which models UGGT1/2
      transferring glucose from dolichyl beta-D-glucosyl phosphate to unfolded
      protein glycans. The Reactome entry states that "UGGT1 and 2 are able to
      distinguish proteins with minor folding defects in the ERQC and
      reglucosylate them." This correctly captures the core enzymatic function
      of UGGT1.
    action: ACCEPT
    reason: >-
      Correctly annotated from a well-curated Reactome reaction that specifically
      models the UGGT1 glucosyltransferase reaction. Consistent with all other
      evidence for GO:0003980.
    supported_by:
      - reference_id: Reactome:R-HSA-548884
        supporting_text: >-
          The UDP-glucose:glycoprotein glucosyltransferases 1 and 2 (UGGT1 and 2) are
          able to distinguish proteins with minor folding defects in the ERQC and
          reglucosylate them, by transferring a glucose (from dolichyl beta-D-glucosyl
          phosphate, DbGP) onto the alpha 1,3 mannose of the b (or c, not shown here)
          branch
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:23349634
  review:
    summary: >-
      IPI annotation for protein binding from Cloutier et al. 2013 (PMID:23349634).
      This study identified UGGT1 as an interactor of METTL23, a lysine
      methyltransferase, by affinity purification coupled to mass spectrometry.
      UniProt confirms "Interacts with METTL23" (PMID:23349634). The interaction
      was identified in the context of a study showing METTL23 preferentially
      associates with molecular chaperones. While the interaction is real, the
      term "protein binding" is uninformative.
    action: REMOVE
    reason: >-
      Per curation guidelines, "protein binding" (GO:0005515) is uninformative and
      should be avoided. The underlying data shows UGGT1 interacts with METTL23
      (a lysine methyltransferase) but this does not inform us about UGGT1's
      molecular function. The interaction may reflect METTL23's role in regulating
      chaperone/quality-control machinery rather than a core function of UGGT1.
    supported_by:
      - reference_id: PMID:23349634
        supporting_text: >-
          A common theme for most of these putative methyltransferases' interactors
          was chaperones, be they of the Hsp70 or Hsp90 variety (see METTL18,
          CAMKMT, METTL21C, METTL22, METTL23, METTL21A, and METTL21B)
- term:
    id: GO:0032991
    label: protein-containing complex
  evidence_type: IDA
  original_reference_id: PMID:23349634
  review:
    summary: >-
      IDA annotation for "protein-containing complex" from Cloutier et al. 2013
      (PMID:23349634). This study showed UGGT1 interacts with METTL23 by AP-MS.
      Additionally, UniProt notes that UGGT1 forms a tight complex with SELENOF
      (PMID:24415556) and is part of a large chaperone multiprotein complex
      comprising DNAJB11, HSP90B1, HSPA5, HYOU, PDIA2, PDIA4, PDIA6, PPIB,
      SDF2L1, and UGGT1 (by similarity from UniProtKB:Q9JLA3). The term
      GO:0032991 is very generic -- it simply indicates the protein is found in
      some complex. While technically correct, it is not very informative.
    action: KEEP_AS_NON_CORE
    reason: >-
      UGGT1 is part of protein complexes (with SELENOF, with METTL23, and as
      part of a larger ER chaperone complex), so the annotation is not wrong.
      However, GO:0032991 is a very generic CC term. Participation in protein
      complexes is not a core defining feature of UGGT1 -- its core function
      is its glucosyltransferase enzymatic activity. The SELENOF complex
      enhances UGGT1 activity (PMID:24415556) but this is regulatory, not a
      core localization.
    supported_by:
      - reference_id: PMID:23349634
        supporting_text: >-
          A common theme for most of these putative methyltransferases' interactors
          was chaperones, be they of the Hsp70 or Hsp90 variety (see METTL18,
          CAMKMT, METTL21C, METTL22, METTL23, METTL21A, and METTL21B)
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:26808496
  review:
    summary: >-
      IPI annotation for protein binding from Liu et al. 2016 (PMID:26808496).
      This study used affinity purification of HCV E2 protein complexes from
      HCV-infected human hepatoma cells and identified UGGT1 (referred to as UGT1)
      as a novel E2 binding partner. The interaction was validated and shown to
      be functionally relevant: "gene silencing of UGT1 in human hepatoma cell
      line Huh7.5.1 markedly decreased the production of infectious HCV, indicating
      a regulatory role of UGT1 in viral lifecycle." While this is an interesting
      finding about UGGT1's role in the HCV lifecycle, the "protein binding" term
      is uninformative and this interaction reflects UGGT1's normal ER quality
      control function on the viral glycoprotein E2.
    action: REMOVE
    reason: >-
      Per curation guidelines, "protein binding" (GO:0005515) is uninformative.
      The interaction between UGGT1 and HCV E2 likely reflects UGGT1's normal
      role in glycoprotein quality control -- HCV E2 is a heavily glycosylated ER
      protein that would be subject to UGGT1's quality control function. This is
      not a novel molecular function of UGGT1 but rather evidence that UGGT1's
      normal glucosyltransferase activity acts on viral glycoproteins as substrates.
    supported_by:
      - reference_id: PMID:26808496
        supporting_text: >-
          85 cellular proteins and three viral proteins were successfully identified
          in three independent trials, among which alphafetoprotein (AFP),
          UDP-glucose: glycoprotein glucosyltransferase 1 (UGT1) and HCV NS4B were
          further validated as novel E2 binding partners.
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:19199708
  review:
    summary: >-
      HDA annotation for extracellular exosome localization from a proteomic
      analysis of human parotid gland exosomes (PMID:19199708). UGGT1 (referred
      to as "UDP-glucose ceramide glucosyltransferase-like 1 isoform 1") was
      identified among 491 proteins in the exosome fraction of parotid saliva
      by MudPIT mass spectrometry. However, the authors note that parotid
      exosomes "lacked endoplasmic reticulum or nuclear resident proteins,"
      suggesting ER-resident proteins should not normally be present in exosomes.
      UGGT1 is an ER-resident protein with a strong ER retention signal (REEL),
      making its presence in exosomes likely a contaminant or artifact of the
      proteomics approach.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      UGGT1 is an established ER-resident protein with a strong ER retrieval signal
      (REEL). Its detection in exosomes from parotid gland saliva (PMID:19199708)
      most likely represents contamination or low-level leakage rather than true
      exosomal localization. The authors themselves note that ER-resident proteins
      should not be present in true exosomes. High-throughput proteomics of
      exosome fractions frequently identify ER contaminants. Extracellular exosome
      is not a meaningful localization for UGGT1.
    supported_by:
      - reference_id: PMID:19199708
        supporting_text: >-
          we found that parotid exosomes lacked endoplasmic reticulum or nuclear
          resident proteins, distinguishing them from apoptotic bodies or shed
          membranes 19 , 22 , 31
- term:
    id: GO:0005788
    label: endoplasmic reticulum lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-548884
  review:
    summary: >-
      TAS annotation for ER lumen localization from Reactome reaction R-HSA-548884.
      UGGT1 is modeled in Reactome as a soluble ER lumen protein that catalyzes
      the reglucosylation of misfolded glycoproteins. This is consistent with
      UniProt's annotation of SUBCELLULAR LOCATION as "Endoplasmic reticulum lumen"
      and with the experimental evidence from PMID:10694380 showing ER localization
      and the presence of an ER retrieval signal (REEL).
    action: ACCEPT
    reason: >-
      UGGT1 is a well-established ER lumen protein. Reactome correctly places it
      in the ER lumen for its reglucosylation reaction. Consistent with the IEA
      annotation from UniProt and experimental evidence (PMID:10694380).
    supported_by:
      - reference_id: PMID:10694380
        supporting_text: >-
          HUGT1 encodes a 1555 amino acid polypeptide that, upon cleavage of an
          N-terminal signal peptide, is predicted to produce a soluble 173 kDa
          protein with the ER retrieval signal REEL.
- term:
    id: GO:0005793
    label: endoplasmic reticulum-Golgi intermediate compartment
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation for ERGIC localization transferred from experimentally-verified
      orthologs by curator judgment. UniProt annotates UGGT1 to the ERGIC based on
      both PROSITE ER-targeting rules and experimental evidence (PMID:10694380).
      The ISS annotation is consistent with the IEA annotation to the same term and
      with the known biology of UGGT1 as a protein that cycles through the early
      secretory pathway via its REEL retrieval signal.
    action: ACCEPT
    reason: >-
      Consistent with the IEA annotation and UniProt subcellular location data.
      UGGT1 contains the REEL retrieval signal enabling cycling through the ERGIC.
      The ISS transfer from orthologs is well-supported.
    supported_by:
      - reference_id: PMID:10694380
        supporting_text: >-
          HUGT1 encodes a 1555 amino acid polypeptide that, upon cleavage of an
          N-terminal signal peptide, is predicted to produce a soluble 173 kDa
          protein with the ER retrieval signal REEL.
- term:
    id: GO:0051082
    label: unfolded protein binding
  evidence_type: IDA
  original_reference_id: PMID:10694380
  review:
    summary: >-
      The IDA annotation to GO:0051082 from PMID:10694380 reflects the experimental
      observation that UGGT1 selectively recognizes and acts upon misfolded/unfolded
      glycoproteins. Arnold et al. (2000) demonstrated that HUGT1 (UGGT1) extracts
      show a 27-fold increase in transfer of [14C]glucose from UDP-[14C]glucose to
      denatured substrates. The assay measured glucosyltransferase activity toward
      denatured substrates, not an independent binding activity. UGGT1's interaction
      with unfolded glycoproteins is substrate recognition intrinsic to its
      glucosyltransferase catalytic cycle: the N-terminal domain senses folding
      defects, and the C-terminal catalytic domain then reglucosylates the substrate.
      UniProt describes the FUNCTION as "Recognizes glycoproteins with minor folding
      defects. Reglucosylates single N-glycans near the misfolded part of the protein."
      This is an enzymatic activity, not a standalone binding function. The term
      GO:0051082 is also being obsoleted (go-ontology#30962).
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      The experimental evidence in PMID:10694380 demonstrates glucosyltransferase
      activity (glucose transfer to denatured substrates), which inherently requires
      substrate recognition/binding. Annotating this as "unfolded protein binding"
      separately from the glucosyltransferase activity is an over-annotation -- it
      conflates enzymatic substrate recognition with an independent molecular function.
      UGGT1 is not a chaperone that simply binds and holds unfolded proteins; it is an
      enzyme that recognizes misfolded glycoprotein substrates and catalytically
      reglucosylates them. The core molecular function is fully captured by GO:0003980
      (UDP-glucose:glycoprotein glucosyltransferase activity). Furthermore, GO:0051082
      is being obsoleted per go-ontology#30962.
    supported_by:
      - reference_id: PMID:10694380
        supporting_text: >-
          UDP-glucose:glycoprotein glucosyltransferase (UGT) is a soluble protein of
          the endoplasmic reticulum (ER) that operates as a gatekeeper for quality
          control by preventing transport of improperly folded glycoproteins out of the
          ER.
      - reference_id: PMID:10694380
        supporting_text: >-
          Extracts from HUGT1-transfected cells displayed a 27-fold increase in the
          transfer of [(14)C]glucose from UDP-[(14)C]glucose to denatured substrates.
- term:
    id: GO:0003980
    label: UDP-glucose:glycoprotein glucosyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:10694380
  review:
    summary: >-
      IDA annotation for the core enzymatic activity from the foundational
      characterization paper by Arnold et al. 2000 (PMID:10694380). This study
      cloned HUGT1 (UGGT1), expressed it in COS-1 cells, and demonstrated a 27-fold
      increase in glucose transfer from UDP-glucose to denatured glycoprotein
      substrates. Site-directed mutagenesis of highly conserved residues (D1452A,
      Q1453A, D1454A, L1455A, P1456A, N1457A) in the catalytic domain identified
      four residues essential for catalytic function. This is the primary
      experimental evidence establishing UGGT1 as a UDP-glucose:glycoprotein
      glucosyltransferase.
    action: ACCEPT
    reason: >-
      Foundational direct assay evidence for UGGT1's core molecular function.
      Arnold et al. (PMID:10694380) performed definitive enzymatic assays
      (radiolabeled glucose transfer) and site-directed mutagenesis confirming
      the glucosyltransferase activity. This is the gold-standard IDA evidence.
    supported_by:
      - reference_id: PMID:10694380
        supporting_text: >-
          Extracts from HUGT1-transfected cells displayed a 27-fold increase in the
          transfer of [(14)C]glucose from UDP-[(14)C]glucose to denatured substrates.
      - reference_id: PMID:10694380
        supporting_text: >-
          Site-directed alanine mutagenesis within a highly conserved region of HUGT1
          identified four residues that are essential for catalytic function.
- term:
    id: GO:0005783
    label: endoplasmic reticulum
  evidence_type: IDA
  original_reference_id: PMID:10694380
  review:
    summary: >-
      IDA annotation for ER localization from Arnold et al. 2000 (PMID:10694380).
      The study showed that UGGT1 (HUGT1) is localized to the ER, consistent with
      its signal peptide, ER retrieval signal (REEL), and function as an ER-resident
      quality control enzyme. The study expressed HUGT1 in COS-1 cells and obtained
      protein localized to the ER for enzymatic activity assays.
    action: ACCEPT
    reason: >-
      Direct experimental evidence of ER localization from the characterization
      study (PMID:10694380). The more specific GO:0005788 (ER lumen) is also
      annotated, but GO:0005783 is acceptable as the parent term confirmed by
      this IDA.
    supported_by:
      - reference_id: PMID:10694380
        supporting_text: >-
          HUGT1 encodes a 1555 amino acid polypeptide that, upon cleavage of an
          N-terminal signal peptide, is predicted to produce a soluble 173 kDa
          protein with the ER retrieval signal REEL.
- term:
    id: GO:0051084
    label: "'de novo' post-translational protein folding"
  evidence_type: TAS
  original_reference_id: PMID:10694380
  review:
    summary: >-
      TAS annotation for "de novo post-translational protein folding"
      (GO:0051084), defined as "the process of assisting in the correct
      noncovalent folding of newly formed polypeptides or folding intermediates."
      UGGT1 does participate in the protein folding quality control cycle by
      reglucosylating misfolded glycoproteins so they can re-engage with
      calnexin/calreticulin for further folding attempts (PMID:10694380,
      PMID:40267907). However, UGGT1 itself is not a chaperone that directly
      assists in protein folding. It is an enzyme that tags misfolded proteins
      for re-entry into the calnexin/calreticulin chaperone cycle. The term
      implies direct folding assistance, which is misleading for UGGT1. A
      more accurate process annotation would be one reflecting its role in
      protein quality control in the ER or N-linked glycosylation.
    action: MODIFY
    reason: >-
      UGGT1 does not directly fold proteins. It is an enzyme (glucosyltransferase)
      that acts as a folding sensor, recognizing misfolded glycoproteins and
      reglucosylating them so they can re-bind calnexin/calreticulin for another
      round of folding. The actual folding is performed by the calnexin/calreticulin
      chaperone system. "De novo post-translational protein folding" implies direct
      chaperone activity, which is inaccurate for UGGT1. A better process term
      would be GO:0006487 (protein N-linked glycosylation) or GO:0097359
      (UDP-glucosylation), which more accurately reflect UGGT1's enzymatic role
      in the quality control cycle.
    proposed_replacement_terms:
      - id: GO:0006487
        label: protein N-linked glycosylation
    additional_reference_ids:
      - PMID:40267907
    supported_by:
      - reference_id: PMID:40267907
        supporting_text: >-
          UGGT1 identifies and reglucosylates misfolded proteins, resulting in ER
          retention for re-binding to CNX/CRT to enable correct folding.
      - reference_id: PMID:10694380
        supporting_text: >-
          UDP-glucose:glycoprotein glucosyltransferase (UGT) is a soluble protein of
          the endoplasmic reticulum (ER) that operates as a gatekeeper for quality
          control by preventing transport of improperly folded glycoproteins out of the
          ER.
core_functions:
- description: >-
    UGGT1 catalyzes the reglucosylation of N-glycans on misfolded glycoproteins
    in the ER lumen, serving as the central folding sensor and checkpoint of the
    calnexin/calreticulin quality control cycle. Its seven-domain architecture
    (TRXL1-4, betaS1-2, GT24 catalytic domain) provides interdomain
    conformational flexibility that enables recognition of diverse
    molten-globule-like folding intermediates and glucosylation of glycans at
    variable distances from misfolded regions (DOI:10.1073/pnas.1703682114).
    UGGT1 writes a site-selective "glyco-code" that programs which ER chaperones
    engage substrates at specific glycosylation sites
    (DOI:10.1016/j.molcel.2023.11.006). This reglucosylation competes with
    EDEM-family mannose trimming in a "tug-of-war" that determines substrate
    fate between refolding and ERAD commitment
    (DOI:10.1101/2023.10.18.562958). UGGT1 also promotes substrate solubility
    by maintaining misfolded glycoproteins in the lectin-chaperone cycle,
    reducing insoluble aggregation (DOI:10.1091/mbc.e13-02-0101). Activity is
    modulated by the partner selenoprotein SELENOF/SEP15, which affects a
    subset of UGGT1 clients (DOI:10.1073/pnas.2315009121).
  molecular_function:
    id: GO:0003980
    label: UDP-glucose:glycoprotein glucosyltransferase activity
  directly_involved_in:
    - id: GO:0006487
      label: protein N-linked glycosylation
    - id: GO:0097359
      label: UDP-glucosylation
  locations:
    - id: GO:0005788
      label: endoplasmic reticulum lumen
    - id: GO:0044322
      label: endoplasmic reticulum quality control compartment
  supported_by:
    - reference_id: PMID:10694380
      supporting_text: >-
        Extracts from HUGT1-transfected cells displayed a 27-fold increase in the
        transfer of [(14)C]glucose from UDP-[(14)C]glucose to denatured substrates.
    - reference_id: PMID:40267907
      supporting_text: >-
        Molecular studies showed that pathogenic UGGT1 variants impair UGGT1
        glucosylation and catalytic activity, disrupt mRNA splicing, or inhibit
        endoplasmic reticulum (ER) retention.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000108
  title: Automatic assignment of GO terms using logical inference, based on on inter-ontology
    links
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:10694380
  title: Two homologues encoding human UDP-glucose:glycoprotein glucosyltransferase
    differ in mRNA expression and enzymatic activity.
  findings: []
- id: PMID:17353931
  title: Large-scale mapping of human protein-protein interactions by mass spectrometry.
  findings: []
- id: PMID:19199708
  title: Proteomic analysis of human parotid gland exosomes by multidimensional protein
    identification technology (MudPIT).
  findings: []
- id: PMID:23349634
  title: A newly uncovered group of distantly related lysine methyltransferases preferentially
    interact with molecular chaperones to regulate their activity.
  findings: []
- id: PMID:24415556
  title: Both isoforms of human UDP-glucose:glycoprotein glucosyltransferase are
    enzymatically active.
  findings: []
- id: PMID:26808496
  title: Comparative Proteomics Reveals Important Viral-Host Interactions in HCV-Infected
    Human Liver Cells.
  findings: []
- id: PMID:40267907
  title: Bi-allelic UGGT1 variants cause a congenital disorder of glycosylation.
  findings: []
- id: Reactome:R-HSA-548884
  title: UGGT1,2 transfers glucose from DbGP to (un)folded protein:(GlcNAc)2 (Man)8b
  findings: []
- id: Reactome:R-HSA-901032
  title: ER Quality Control Compartment (ERQC)
  findings: []
- id: DOI:10.1073/pnas.1703682114
  title: Interdomain conformational flexibility underpins the activity of UGGT, the
    eukaryotic glycoprotein secretion checkpoint.
  findings:
  - statement: >-
      UGGT1 has a seven-domain topology with four N-terminal thioredoxin-like
      domains (TRXL1-4) arranged in an arc, two beta-sandwich domains, and a
      C-terminal GT24 catalytic domain
  - statement: >-
      Interdomain conformational flexibility is required for activity;
      engineered interdomain disulfides that rigidify UGGT reduce catalytic
      function
- id: DOI:10.1016/j.molcel.2023.11.006
  title: ER chaperones use a protein folding and quality control glyco-code.
  findings:
  - statement: >-
      UGGT1-mediated reglucosylation writes a programmable glyco-code that
      determines which ER chaperones engage substrates at specific
      glycosylation sites
  - statement: >-
      UGGT1 deletion reduces monoglucosylated AAT by more than half; UGGT1/2
      double deletion abolishes glucosylation
  - statement: >-
      UGGT preferentially modifies particular glycosylation sites (e.g., AAT
      N247 more than N83), supporting positional logic in the glyco-code
- id: DOI:10.1101/2023.10.18.562958
  title: UGGT1-mediated reglucosylation of N-glycan competes with ER-associated degradation
    of unstable and misfolded glycoproteins.
  findings:
  - statement: >-
      UGGT1 delays degradation of misfolded glycoproteins in a tug-of-war
      between reglucosylation/refolding and EDEM-mediated mannose trimming
      that commits substrates to ERAD
  - statement: >-
      UGGT2 protein levels are ~6.9% (HCT116) and ~29.8% (HeLa) of UGGT1,
      establishing UGGT1 as the dominant mammalian reglucosyltransferase
- id: DOI:10.1073/pnas.2315009121
  title: Insights into the interaction between UGGT, the gatekeeper of folding in the
    ER, and its partner, the selenoprotein SEP15.
  findings:
  - statement: >-
      AlphaFold-multimer predicts a specific UGGT1/SEP15 complex with SEP15
      selenocysteine positioned proximal to UGGT1 catalytic region
  - statement: >-
      About 27% of expressed SEP15 co-occurs with UGGT1; interface mutants
      reduce binding to ~3.8-6.5%
  - statement: >-
      SEP15 affects a subset of UGGT1 clients rather than globally shifting
      all UGGT activity (26 proteins with significantly altered glucosylation
      in SELENOF-null cells)
- id: DOI:10.1091/mbc.e13-02-0101
  title: UDP-glucose:glycoprotein glucosyltransferase (UGGT1) promotes substrate solubility
    in the endoplasmic reticulum.
  findings:
  - statement: >-
      UGGT1 enzymatic activity increases the soluble fraction of misfolded
      alpha-1 antitrypsin variants and reduces insoluble aggregation,
      maintaining ER solubility of folding intermediates through
      monoglucosylation and lectin-chaperone cycling
- id: DOI:10.7554/eLife.63997
  title: Quantitative glycoproteomics reveals cellular substrate selectivity of the
    ER protein quality control sensors UGGT1 and UGGT2.
  findings:
  - statement: >-
      UGGT1 preferentially modifies large, complex glycoproteins (often
      membrane/plasma-membrane targeted), while UGGT2 preferentially modifies
      smaller soluble/lysosomal proteins